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Malaria causes 300-500 million clinical cases and 1-3 million deaths per year, the 
majority of which occur in young African children.  Ingestion of hemozoin by peripheral 
blood mononuclear cells (PBMC) initiates the cytokine-mediated cascade of immune 
dysregulation in malaria.  Innate immunity plays a critical role in protective responses 
against infection, which are determined by an appropriate balance between pro- and anti-
inflammatory mediators.  Pro-inflammatory mediators (TNF-α, IL-12, IFN-γ) that control 
parasitemia also contribute to pathology.  Over-production of immunomodulatory 
cytokines (TGF-β1, IL-10) suppresses the protective pro-inflammatory immune response.  
The effects of hemozoin on hematological outcomes and inflammatory mediator 
production in children with malarial anemia and the temporal kinetics of hemozoin-
induced cytokine dysregulation in cultured PBMC were investigated in this study.   
Hematological analyses of healthy control (HC), uncomplicated malaria (UM), mild 
malarial anemia (MlMA), moderate malarial anemia (MdMA), and severe malarial 
anemia (SMA) groups revealed that age, temperature, and all erythrocyte, leukocyte, and 
platelet indices were significantly different between clinical categories.  Neither 
parasitemia nor the prevalence of high density parasitemia (HDP) differed significantly 
between clinical groups.  Stratification of study participants according to proportion of 
pigment-containing monocytes (PCM) demonstrated that parasitemia, HDP, temperature, 
and most leukocyte, erythrocyte, and platelet indices were significantly different between 
0%, ≤ 10%, and > 10% PCM categories.  The > 10% PCM category contained children 
with the lowest hemoglobin, hematocrit, and erythrocyte counts and the greatest 
proportion of children with SMA.  Plasma IFN-α, IL-4, IL-6, IL-10, and IL-12p40/p70 
levels differed significantly between clinical categories but not between UM and SMA 
groups.  Plasma IFN-α, IFN-γ, TNF -α, IL-1β, IL-2, IL-4, IL-6, IL-10, and IL-12p40/p70 
 v
were not significantly associated with % PCM.  β-hematin-induced IL-1β, IL-2, IL-6, IL-
12p35, IL-12p40, IL-18, IFN-α, IFN-γ, TNF-α, LT-α, NOS-2A, COX-1, COX-2, IL-4, 
IL-10, and TGF-β1 expression in cultured PBMC revealed a pro-inflammatory response 
that varied in magnitude among individuals.  Importantly, innate inflammatory mediators 
modulate the adaptive immune response to Plasmodium parasites.  Of public health 
significance, a better understanding of the molecular mechanisms governing these 
responses will facilitate the development of more immunogenic vaccines, through 
inclusion of cytokines or other compounds that activate the innate immune system.  
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1.0    INTRODUCTION 
 
In humans, the protozoan parasites Plasmodium vivax, Plasmodium malariae, 
Plasmodium ovale, and Plasmodium falciparum cause malaria, a disease transmitted by 
the bite of an infected female Anopheles mosquito.  Endemic to tropical and subtropical 
regions of the world, malaria causes 300-500 million clinical cases resulting in one to 
three million deaths per year (Stevenson and Riley, 2004; Struik and Riley, 2004; Snow 
et al., 1999; Zambrano-Villa, 2002). Whereas adults living in hyperendemic areas 
typically develop semi-immunity following frequent episodes of childhood malaria, 
children may develop severe malaria with hyperparasitemia and life-threatening 
complications such as severe anemia, hypoglycemia, and cerebral malaria (Perkins et al., 
1999).  Plasmodium falciparum produces the majority of severe malaria cases and deaths, 
including up to 35% of infant and child mortality in some areas of Africa (Korenromp et 
al., 2003).  Children less than five years of age are at greatest risk of mortality due to 
their non-immune status (Perkins et al., 1999).  Malaria control methods including the 
use of insecticide-treated bed nets, vector control, and chemotherapy have not achieved 
substantial reductions in morbidity and mortality (Struik and Riley, 2004).  In addition, 
resistance against anti-malarial drugs such as chloroquine and sulphadoxine-
pyrimethamine has developed in recent years (Ridley, 2003).  Currently, the only 
effective treatment for multidrug-resistant malaria are the sesquiterpene lactone 
artemisinin drugs (derived from the Chinese herb qinghao) (Eckstein-Ludwig et al., 
2003; Ridley, 2003). Development of an effective vaccine against P. falciparum malaria 
has been slow, due in part to numerous species- and stage-specific parasite target antigens 
and to the lack of long-term immunological memory responses in the human host (Struik 
and Riley, 2004; Stevenson and Riley, 2004).  For these reasons, understanding the innate 
immune responses that mediate protection against malaria will be critical in designing 
alternative therapies.  The purpose of this study is to investigate the impact of naturally 
1 
acquired Plasmodium falciparum hemozoin on hematological outcomes and 
inflammatory mediator production in infants and young children with malarial anemia, 
and the temporal kinetics of hemozoin-induced cytokine transcript dysregulation in 
cultured human peripheral blood mononuclear cells.  
 
1.1    P. falciparum Life Cycle 
The life cycle of P.  falciparum is complex, having intra- and extracellular stages  
(Figure 1).  During a bloodmeal, the female Anopheles mosquito injects haploid 
sporozoites into the host’s bloodstream.  These sporozoites migrate to the liver and 
invade hepatocytes.  Following five to seven days of replication by asexual mitosis, these 
sporozoite-infected hepatocytes produce exoerythrocytic schizonts that rupture and 
release thousands of merozoites into the bloodstream (Struik and Riley, 2004).  
Merozoites invade erythrocytes and develop into erythrocytic schizonts via asexual 
mitotic replication.  Each erythrocytic schizont contains up to 20 daughter merozoites, 
which upon schizont rupture invade new erythrocytes and give rise to new schizonts.  
The rupture of erythrocytic schizonts is characterized by episodes of fever, rigors, nausea, 
and headaches that result from the systemic pro-inflammatory cytokine cascade initiated 
by cells of the innate immune system (Miller et al., 2002).  This cyclical pattern of blood-
stage infection continues for 48-72 hours (Struik and Riley, 2004).  During 
intraerythrocytic infection, parasites catabolize hemoglobin as a source of amino acids 
and transform toxic heme released during hemoglobin catabolism into the insoluble, inert 
crystal hemozoin (malarial pigment) (Chong and Sullivan, 2003).  In some instances, 
merozoites do not invade erythrocytes, but instead differentiate into male and female 
gametocytes.   Following ingestion by a mosquito, these gametocytes develop into 
extracellular gametes.  Male and female gametes then fuse during sexual replication in 
the mosquito midgut to produce motile zygotes that penetrate the midgut wall and form 
oocysts.  Following meiosis, oocysts develop into haploid sporozoites that migrate to the 
mosquito salivary glands and can be transmitted to the next host, beginning the cycle  
anew.  
2 
  
 
Figure 1.  Plasmodium falciparum life cycle in the human host and mosquito vector.  The female 
Anopheles mosquito injects haploid sporozoites into the host’s bloodstream, where they migrate to the liver 
to invade hepatocytes.  Sporozoites undergo 5-7 days of replication by asexual mitosis to produce 
exoerythrocytic (liver) schizonts.  This stage of infection is asymptomatic.  Upon rupture, liver schizonts 
release thousands of merozoites into the bloodstream.  Merozoites invade erythrocytes and develop into 
erythrocytic schizonts via asexual mitotic replication.  Erythrocytic schizonts rupture, releasing up to 20 
daughter merozoites that invade new erythrocytes and give rise to new schizonts.  The rupture of 
erythrocytic schizonts triggers a cascade of pro-inflammatory cytokines leading to episodes of fever, rigors, 
nausea, and headaches.  This cyclical pattern of blood-stage infection lasts for 48-72 hours.  Some 
merozoites do not invade erythrocytes, but instead differentiate into male and female gametocytes that 
develop into extracellular gametes following ingestion by a mosquito.  Male (micro) and female (macro) 
gametes fuse during sexual reproduction in the mosquito midgut, producing motile zygotes (ookinetes) that 
penetrate the midgut wall and form oocysts.  Oocysts develop into haploid sporozoites via meiosis.  
Infective sporozoites migrate to the mosquito salivary glands, where they can be transmitted to the next 
host.   (adapted with permission from Struik and Riley, 2004) 
 
 
1.2    Properties of Hemozoin and β-hematin 
Hemozoin (malarial pigment) is formed in the digestive vacuoles of late 
trophozoites and schizonts during intraerythrocytic development as the end product of 
host hemoglobin digestion (Day et al., 1996).  During this process, heme released as a 
3 
byproduct is autoxidized to toxic hematin [aquaferriprotoporphyrin IX, H2O-
Fe(III)PPIX], which is subsequently detoxified by conversion to hemozoin (Ladan et al., 
1993; Scheibel and Sherman, 1988).  Heme polymerase catalyzes the polymerization of 
hemozoin through linkage of heme groups via iron carboxylate bonds (Slater and Cerami, 
1992; Day et al., 1996).  The core Fe(III)PPIX structure of hemozoin (Figure 2) is 
surrounded by proteins, carbohydrates, lipids, and nucleic acids (Goldie et al., 1990).  
Hemozoin has been shown to induce both pro-inflammatory and anti-inflammatory 
cytokines in cultured peripheral blood mononuclear cells (PBMC) (Pichyangkul et al., 
1994; Mordmüller et al., 1998).  Human monocyte-derived macrophages that 
phagocytose trophozoite-parasitized red blood cells (RBCs) or free pigment are unable to 
degrade the ingested pigment heme, repeat phagocytosis, and generate the oxidative burst 
(Schwarzer et al., 1992).  As such, pigment formation not only protects the parasite from 
toxic heme, but also from the host immune reponse.  The toxicity of hemozoin may be 
attributed to the covalent iron carboxylate bonds that contribute to its stability and 
indigestibility in both the phagolysosome and the parasite food vacuole (Slater et al., 
1991).     
β-hematin (synthetic hemozoin) is a crystalline cyclic dimer of Fe(III)PPIX that is 
chemically, crystallographically, and spectroscopically identical to hemozoin (Egan et 
al., 2001; Fitch and Kanjananggulpan, 1987; Slater et al., 1991; Bohle et al., 1994,1997).   
β-hematin  (Figure 2) is formed by reciprocal iron-carboxylate bonds that link the ionized 
heme-propionate side chain of one Fe(III)PPIX to the central Fe(III) of another (Pagola et 
al., 2000; Egan et al., 2001).  Fe(III)PPIX dimers stack in the crystal lattice to form 
parallel iron porphyrin rings.  Studies in our laboratory have demonstrated that similar to 
hemozoin, β-hematin elicits pro- and anti-inflammatory cytokine synthesis in cultured 
peripheral blood mononuclear cells (PBMC) (Keller et al., 2004a, 2006, manuscript 
submitted). 
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Figure 2.  Structure of hemozoin and β-hematin.  (A) Reciprocal iron-carboxylate Fe(III)PPIX dimer 
(adapted with permission from Tekwani and Walker, 2005).  (B) Packing diagram of the crystal structure of 
β-hematin (core structure of hemozoin).  C atoms are illustrated in grey; O, red; N, green; Fe, blue.  
(adapted with permission from Pagola et al., 2000) 
 
 
1.3    Inflammatory Response/Pathology 
Plasmodium evades the immune response by altering its surface antigens 
throughout the various stages of its life cycle (Bull et al., 1998; Zambrano-Villa et al., 
2002).  Each phase of the life cycle is characterized by the transient expression of 
species-specific proteins that are highly polymorphic and antigenically variable.  The 
erythrocytic stage of P. falciparum infection is responsible for all disease pathology in 
malaria and is characterized by dysregulatory processes that prevent the induction of 
robust immune responses (Luke and Hoffman, 2003).  During schizogony, parasitized red 
blood cells (pRBC) burst, creating RBC ghosts and releasing daughter merozoites and 
hemozoin into the blood stream (Phu et al., 1994).  Scavenger monocytes and neutrophils 
ingest malarial pigment through phagocytosis of mature pRBCs, RBC ghosts, living or 
dead pigment-containing phagocytes, and particulate material released at schizogony 
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(Day et al., 1996).  Ingestion of opsonized hemozoin by monocytes impairs their 
expression of MHC class II molecules, CD54, and CD11c, as well as generation of the 
oxidative burst, protein kinase C activity, and their ability to repeat phagocytosis (Arese 
and Scwarzer, 1997; Schwarzer et al., 1992, 1993, 1998).  Intracellular hemozoin 
released into the circulation upon schizont rupture becomes concentrated in resident 
macrophages of the reticuloendothelial system (Schwarzer et al., 1998).   Impaired 
antigen presentation to T cells results from the suppression of dendritic cell maturation by 
parasitized red blood cells (Urban et al., 1999).  Parasitized red blood cells can also cause 
apoptosis of malaria-specific B cells and T cells (Good, 2005).   
P. falciparum infection is characterized by anemia, metabolic acidosis, and/or 
cerebra
.4    Malarial Anemia 
(MA) is complex and results not only from immune destruction 
of para
l malaria (Stevenson and Riley, 2004).  Disease pathology is caused by the 
destruction of erythrocytes, bone marrow suppression, and impaired circulation resulting 
from peripheral hypotension and the adherence of infected erythrocytes to the vascular 
endothelium (Stevenson and Riley, 2004). Hypoxia, hypoglycemia, and lactic acidosis 
resulting from the increased metabolic demands of the parasite are associated with 
erythrocyte destruction and bone marrow suppression (Stevenson and Riley, 2004). 
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Malarial anemia 
sitized erythrocytes, but also from excess removal of nonparasitized erythrocytes 
and bone marrow dysfunction (Ekvall, 2003). The severity of anemia in acute malaria 
most likely depends on the degree of RBC destruction, whereas ineffective erythropoiesis 
and dyserythropoiesis play a greater a role in chronic infection with low parasitemia.  
Severe malarial anemia (SMA) is the predominant clinical manifestation of severe 
falciparum malaria in areas of holoendemic (high/sustained) transmission, whereas 
cerebral malaria and metabolic acidosis are more prevalent in areas of lower/seasonal 
transmission (Day, 1996; Ekvall, 2003).  In addition, children aged less than 24 months 
are more susceptible to malarial anemia, whereas cerebral malaria peaks in children 
approximately 3 years of age (Ekvall, 2003).  The leading cause of death among children 
with malaria, SMA accounts for 190,000-974,000 deaths per year in children less than 
five years of age (WHO, Children and malaria, http://www.who.int/cmcupload/0/000/ 
6 
015/367/RBMInfosheet6.htm).  Due to antimalarial drug resistance, many children fail to 
clear parasitemia after treatment and remain anemic; others who require blood 
transfusions to survive are at risk of contracting HIV and other blood-borne diseases.  
Destruction of uninfected erythrocytes accounts for more than 90% of erythrocyte 
loss in
e decreased 
respons
 adults with acute uncomplicated malaria, and is the primary cause of severe 
malarial anemia (SMA) (Stoute et al., 2003; Ekvall, 2003).  Several mechanisms are 
thought to play a role in this destruction.  For example, alterations in the membranes of 
non-parasitized RBCs may target them for removal from circulation and destruction in 
the spleen.  Oxygen and nitrogen radicals released from macrophages as a result of pro-
inflammatory cytokine secretion cause oxidative damage to non-parasitized RBCs in the 
form of membrane disruption, which leads to enhanced RBC removal (Griffiths et al., 
2001; Perkins et al., 2000; Greve et al., 1999).  Reduced RBC deformability, which 
correlates with disease severity and degree of anemia, may play a role in non-parasitized 
RBC destruction by immune effector cells in malaria (Dondorp et al., 1999).  Reduced 
RBC deformability is also thought to be responsible for the removal of normal senescent 
erythrocytes from the circulation.  In addition, parasite-induced complement activation 
may contribute to RBC destruction.  Complement can act synergistically with Ig to 
induce phagocytosis or may cause direct lysis of non-parasitized RBCs (Ekvall, 2003).  
Furthermore, deficiencies in surface complement regulatory proteins (such as CR1 and 
CD55) that protect RBCs from complement-mediated lysis have been implicated in the 
pathogenesis of malarial anemia (Devine, 1991; Waitumbi et al., 2000).        
Bone marrow dysfunction in malarial anemia results from th
iveness of erythroid progenitor cells to erythropoietin and to the impaired 
production of erythropoietin, both of which are regulated by inflammatory cytokines 
(Ekvall, 2003).  Elevated plasma TNF and IL-10 levels are found in children with 
malarial anemia and high-density parasitemia, and a low IL-10/TNF ratio is specifically 
associated with malarial anemia in these children (Kurtzhals et al., 1998; Mordmüller et 
al., 1997; Othoro et. al., 1999; Shaffer et al., 1991).  Since IL-10 inhibits P. falciparum-
induced TNF production, low levels of IL-10 may facilitate high levels of TNF, resulting 
in anemia (Ho et al., 1995, 1998).  Acute childhood malaria is characterized by bone 
marrow suppression, sometimes in conjunction with decreased erythropoiesis (Kurtzhals 
7 
et al., 1997).  Hyperactive bone marrow, accompanied by morphologic dyserythropoiesis 
and the absence of reticulocyte release, is more common in chronic malaria 
(Wickramasinghe and Abdalla, 2000).  Though elevated erythropoietin levels in African 
children with malaria would seem to indicate increased erythropoiesis, bone marrow 
suppression still occurs (Nussenblatt et al., 2001; Menendez et al., 2001; Verhoef et al., 
2001).  Possible mechanisms for this inhibition include the direct effect of 
parasites/parasite products on the bone marrow, macrophage dysfunction, secretion of 
cytokines such as TNF-α, IFN-γ, and MIF (macrophage migration inhibitory factor) by 
activated T cells, and the local release of reactive oxygen and nitrogen species (Clark and 
Chaudri, 1988; Martiney et al., 2000; Kremsner et al., 2000; Kun et al., 2001; Schwarzer 
et al., 1992; Wickramasinghe and Abdalla, 2000). 
 
1.5    Cytokine Dysregulation   
erythrocytes contributes significantly to P. falciparum 
malaria
While the destruction of 
, the same pro-inflammatory mediators that contribute to the control of parasite 
replication also increase the severity of the disease (Kwiatkowski et al., 1997; Hunt and 
Grau, 2003; Artavanis-Tsakonas et al., 2003a; Riley, 1999).  Like many infectious and 
noninfectious acute diseases, malaria may be characterized as a cytokine release 
syndrome (Clark et al., 2004).  The rupture of schizont-infected erythrocytes triggers a 
cascade of inflammatory cytokines that can result in death (Artavanis-Tsakonas et al., 
2003; Riley, 1999).  As illustrated in Figure 3, the differential effects of hemozoin 
ingestion by phagocytes on cytokine production play a critical role in this dysregulation.  
For example, the pro-inflammatory cytokine IL-12 is required during the early cell-
mediated immune response to malaria infection (Crutcher et al., 1995; Mosmann and 
Coffman, 1989; Trinchieri, 1993).  IL-12-induced up-regulation of TNF-α and IFN-γ 
facilitate parasite killing, partially due to increased production of nitric oxide (NO) 
(Stevenson et al., 1995; Yoshimoto et al., 1998).    However, IL-12 production by 
monocytes is suppressed following the ingestion of hemozoin, whereas TNF-α and IL-10 
production are enhanced (Mordmüller et al., 1998).  Anti-inflammatory IL-10 inhibits IL-
12 production by monocytes, and elevated levels of TNF-α promote the development of 
severe anemia (Luty et al., 2000; Storkus et al., 1998).  Increased NO production has 
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been associated with accelerated parasite clearance in Gabonese children and adults with 
malaria, but prolonged overproduction of NO can lead to SMA through suppression of 
erythropoiesis and induction of apoptosis in CD34+ hematopoietic stem cells (Kremsner 
et al., 1996; Reykdal et al., 1999; Shami and Weinberg, 1996). Furthermore, low IL-12 
levels have been associated with increased susceptibility to severe P. falciparum malaria 
(Luty et al., 2000).        
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Figure 3. odel of innate immune response to malaria.  Protective immunity against malaria is regulated by both pro- and anti-
inflamma ry cytokines, the balance of which determines disease outcome. Pro-inflammatory mediators are illustrated in red text, 
and anti-inflammatory cytokines are illustrated in green text.  Enzymes and effector molecules are shown in blue.  Solid lines 
represent positive signaling, whereas dashed lines represent suppression.  Exposure of monocytes/macrophages to parasitized red 
blood cells (pRBC) or hemozoin initiates the inflammatory cascade through release of IL-12.  Alone or in conjunction with IL-18, 
IL-12 promotes IFN-γ secretion from T helper 1 cells.  Activated T lymphocytes secrete IL-2, which acts in an autocrine fashion 
to promote T cell growth and differentiation.  IL-12 and IFN-γ stimulate monocytes/macrophages to produce TNF-α, which 
facilitates parasite killing through generation of toxic free radicals such as nitric oxide (NO), via the enzymatic activity of 
inducible nitric oxide synthase (iNOS).  Production of IFN-α by monocytes and of LT-α by T- or B lymphocytes also induces 
NO-mediated parasite killing.  While pro-inflammatory mediators such as IL-1β, IL-6, and TNF-α control parasitemia, elevated 
levels of these cytokines promote the development of severe malarial anemia (SMA) through suppression of erythropoiesis. In 
response to parasitic products, cyclooxygenase-2 (COX-2) is inducibly expressed to enhance prostaglandin E2 (PGE2) synthesis.  
TNF-α-induced PGE2 negatively regulates production of TNF-α and of the IL-12p40 subunit.  Induction of anti-inflammatory 
mediators is required to counteract the pathological effects of prolonged pro-inflammatory cytokine production during acute 
malaria.  Monocytic release of anti-inflammatory cytokines IL-10 and TGF-β1 down-regulates the pro-inflammatory response 
through suppression of IL-12, IFN-γ, and TNF-α.  In addition, IL-4 production by T cells activates B lymphocytes and induces 
TH2 cell differentiation. 
  M
to
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However, the ability of immunoregulatory cytokines to control circulating levels 
of pro-inflammatory cytokines may facilitate parasite clearance without triggering 
pathology (Stevenson and Riley, 2004).  In mice and humans, IL-10 and TGF-β 
(transforming-growth factor-β) negatively regulate both innate and adaptive immune 
responses by inhibiting pro-inflammatory cytokine responses (IFN-γ, IL-12) (Omer and 
Riley, 1998; Omer et al., 2003a; Li et al., 2003; Kurtzhals et al., 1998; Dodoo et al., 
2002; Tsutsui and Kamiyama, 1999).  As in the case of IL-12, reduced plasma levels of 
TGF-β are characteristic of severe malaria (Perkins et al., 2000).  IL-10 also suppresses 
TNF-α and IL-1β production through inhibition of NF-κB (Wang et al., 1995).  NO 
serves a homeostatic role in falciparum malaria by down-regulating TNF-α (which 
generates NO via the enzymatic activity of inducible nitric oxide synthase, iNOS/NOS-
2A) through inhibition of NF-κB (Iuvone et al., 1996; Otterbein et al., 2000; Sarady et 
al., 2002).   NO further reduces TNF-α levels by inhibiting the adhesion of pRBCs to the 
vascular endothelium (which is required for maximal TNF production) (Serirom et al., 
2003; O’Dea and Pasvol, 2003).  The balance of pro- and anti-inflammatory cytokines 
and effector molecules determines whether a protective or a pathogenic response 
develops (Perkins et al., 2000).  The mechanism by which this balance is achieved is 
unknown, but has been linked to naturally acquired immunity to malaria in endemic 
areas, whereby chronic, low-grade infections allow the host to remain asymptomatic 
(premunition) (Stevenson and Riley, 2004; Struik and Riley, 2004; Targett, 2005).  
 
1.6    Hypothesis and Objectives 
Since the ingestion of hemozoin by peripheral blood mononuclear cells (PBMC) 
initiates the cytokine-mediated cascade of immune dysregulation in malaria, we decided 
to investigate the temporal effects of malarial pigment on cytokine production in vitro.  In 
addition, as MA is the most prevalent clinical outcome of pigment-induced immune 
dysregulation in areas of holoendemic P. falciparum transmission (Bloland et al., 1999), 
and SMA is the leading cause of morbidity and mortality among children under 5 years 
of age in these areas (WHO, 2000; Breman et al., 2001), we studied the impact of 
hemozoin on hematological indices and plasma cytokine protein levels in children with 
varying degrees of parasitemia and malarial anemia. 
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   The main hypothesis of this study is that dysregulation in innate immune 
responses to malaria occurs at the level of de novo cytokine transcription.  Furthermore, 
malarial pigment-induced changes in hematological parameters lead to MA.  While level 
of parasitemia is not necessarily predictive of MA or disease severity (Ong’echa et al., 
2006; McElroy et al., 2000), we propose that the percent of pigment-containing 
monocytes in the blood of infected children correlates with the severity of anemia. 
To illustrate the effect of hemozoin on hematological outcomes, blood was drawn 
from parasitemic and aparasitemic children with/without varying degrees of MA.  
Complete blood counts were performed, and study participants (n = 648) were stratified 
by clinical (anemia) category to examine the category-specific effects of malarial 
pigment on hematological measurements.  Parasitemic study participants were then 
stratified according to percent of pigment-containing monocytes (% PCM) to determine if 
pigment content was related to severity of anemia.  To determine the relationship 
between in vivo innate inflammatory mediator production and monocytic acquisition of 
hemozoin, plasma levels of IL-12p40/p70, IFN-α, IFN-γ, TNF-α, IL-1β, IL-2, IL-4, IL-6, 
and IL-10 from children (n = 189) with/without varying degrees of MA were determined 
by multiplex assay.  Parasitemic study participants were further stratified according to 
blood content of pigment-containing monocytes to examine whether plasma cytokine 
levels were correlated with % PCM.     
To investigate the temporal effect of pigment on in vitro cytokine transcript 
production, β-hematin (synthetic hemozoin), which is chemically, crystallographically, 
and spectroscopically identical to the core ferriprotoporphyrin IX [Fe(III)PPIX] of 
hemozoin (Fitch et al., 1987; Slater et al., 1991; Bohle et al., 1994,1997), was used to 
stimulate cultured PBMC isolated from the blood of malaria-nave donors.  RNA was 
isolated from harvested cells, reverse transcribed into cDNA, and analyzed by 
quantitative real time PCR for expression of the following cytokines:   TNF-α, IL-12A 
(p35), IL-12B (p40), IL-10, TGF-β1, IFN-α, IFN-γ, IL-2, IL-4, IL-6, IL-18, IL-1β, LT-α, 
NOS-2A, COX-1, and COX-2.   
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2.0    MATERIALS AND METHODS 
 
2.1    PBMC Culture and Isolation:  Venous blood (70 mL) from malaria-naïve human 
donors (n = 9) was drawn into heparin-containing vials.  PBMC were isolated using 
ficoll/Hypaque and plated at a density of 1 x 106 cells/mL in Dulbecco’s Modified Eagle 
Medium (DMEM) containing 10% human serum (heat-inactivated at 56°C for 30 min).  
Cultures were stimulated with media alone (controls) or β-hematin (10 μg/mL).  β-
hematin preparations were sonicated an average of 25 times prior to addition to the 
cultures and were vortexed periodically during addition.  Concentrations of β-hematin 
used in the present study were comparable to physiological levels of hemozoin measured 
in children with severe malaria (Keller et al., 2004b).   
 
2.2    β-hematin Preparation:  β-hematin was formed according to the method of Egan 
et al. (Egan et al., 2001) by dissolving hemin chloride (bovine, ICN Biomedicals, Aurora, 
OH) in 0.1 M NaOH, followed by the addition of HCl and acetate stock solution (12.8 M, 
pH 5) at 60°C.  After incubation at 60°C for 150 min in the absence of stirring, the 
mixture was centrifuged at 10,000 rpm for 10 min, washed with filter-sterilized H2O, and 
dried on a heat block at 65°C.  The resulting pellet was weighed and resuspended at 1.0 
mg/mL in filter-sterilized H2O.  The resuspended  β-hematin was sonicated thoroughly 
before freezing at -20°C.  Endotoxin levels were determined to be less than 0.25 EU/mL 
(0.05 ng/mL) using the Limulus Amebocyte Lysate test (Cambrex Bio Science, 
Walkersville, MD).   
 
2.3    RNA Isolation:  Following the removal of culture supernatants, 1.0 mL of 
Solution D per 2 x 106 PBMC was added to culture plates, which were stored at -20°C.  
Total RNA, was isolated by the GITC method (Chomczynski and Sacchi, 1987).  
Briefly, thawed PBMC in Solution D were transferred to sterile baked glass tubes.  
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Following addition of 100 μL of 2M sodium acetate (pH 4.0), 1 mL phenol, and 200 μL 
chloroform/isoamyl alcohol (49:1), glass tubes were covered in parafilm and vortexed at 
high speed for 10 min.  Samples were incubated on ice for 30 min, and then centrifuged 
at 3750 rpm for 30 min at 4°C.  Three quarters (750 μL) of the upper aqueous phase of 
each centrifuged sample was transferred to a sterile micro-centrifuge tube.  An equal 
volume of cold isopropanol was added to the extracted RNA in each tube, after which the 
solution was mixed thoroughly and precipitated at -20°C for a minimum of 2 days.  
Precipitated RNA was pelleted by centrifugation at 10,000 rpm for 30 min at 4°C.  
Isopropanol was decanted, and tubes were centrifuged repeatedly to remove residual 
isopropanol with a pipette.  Open tubes were placed upside-down under a fume hood for 
15-30 min to allow isopropanol to evaporate, without complete drying of the RNA pellet.  
RNA was subsequently dissolved on ice with a minimal (15 μL) volume of DEPC-treated 
water.  RNA samples were then tritriated, held on ice for 15 min, and heated at 65°C for 
10 min to solubilize the RNA.  Samples were stored at -20°C.  
 
2.4    Quantitative Real Time RT-PCR:  Total RNA (1 μg/(L) was reverse-transcribed 
into cDNA using a PTC-100 Peltier Thermal Cycler (MJ Research, Inc., Waltham, MA).  
Cytokine gene expression was analyzed by quantitative real time PCR on either an ABI 
Prism 7700 Sequence Detection System, an Applied Biosystems 7500 Real Time PCR 
System, or an ABI Prism 7900HT instrument (Applied Biosystems, Foster City, CA).  
All experiments involving use of the ABI Prism 7900HT instrument were conducted by 
the TaqMan® core facility of the University of Pittsburgh Genomics and Proteomics 
Core Laboratories.  cDNA was amplified in duplicate with the following primer/probe 
sets (Applied Biosystems, Foster City, CA):  TNF-α (Assay ID Number 
Hs00174128m1), IL-12A (p35) (Hs00168405m1), IL-12B (p40) (Hs00233688m1), IL-10 
(Hs00174086m1), TGF-β1 (Hs00171257m1), IFN-γ (Hs00174143), IFN-α 
(Hs00256882s1), IL-2 (Hs00174114m1), IL-4 (Hs00174122m1), IL-6 (Hs00174131m1), 
IL-18 (Hs00155517m1), IL-1β (Hs00174097m1), LT-α (Hs00236874), NOS-2A 
(Hs00167248m1), COX-1 (Hs00377721m1), and COX-2 (Hs00153133m1).  The 
endogenous control gene β-actin [Ascession Number NM001101 (Applied Biosystems, 
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Foster City, CA )] was used as a reference gene to normalize the expression levels of 
target genes by correcting differences in the amount of cDNA loaded between samples.  
No template controls were included in quadruplicate for each gene to control for 
nonspecific background fluorescence.  Data were analyzed using the comparative CT 
method (ΔΔCT) (Keller et al., 2004b).  The change in CT (ΔCT) for each experimental 
sample was derived by subtracting the endogenous control gene (β-actin) CT from the 
experimental gene CT.  The ΔCT for each experimental sample was then subtracted from 
the ΔCT of the control (medium alone) sample.  Fold change was expressed as 2-ΔΔCT 
relative to control conditions.   
 
2.5    Hematology/Malarial Pigment Data:  The ongoing hospital-based study is being 
conducted at the pediatric ward of the Siaya District Hospital in Siaya District, Nyanza 
Province, western Kenya, and at the University of Pittsburgh/KEMRI clinical laboratories 
(Ong’echa et al., 2006).  Study participants (n = 648) included children from 0 to 3 years 
of age, who had visited the hospital with symptoms of malaria.  Heel/finger prick blood 
(< 100μL) was used to screen for hemoglobin (Hb) levels and to prepare blood smears for 
the determination of parasitemia.  Hb levels were determined using a HemoCue system 
(HemoCue AB, Angelholm, Sweden).  Geimsa-stained blood smears were examined 
under oil immersion for malaria parasites, which were counted against 300 leukocytes.  
Parasite densities (/μL of blood) were estimated using leukocyte counts (/μL of blood) 
for the same samples. Complete blood counts were performed with a Beckman Coulter® 
AcT diff2™ coulter counter (Beckman-Coulter Corporation, Miami, USA).  Reticulocyte 
counts were determined from thin blood films stained with new methylene blue.  
Reticulocyte index (RI) was calculated as reticulocyte count (%) x (hematocrit/0.36) 
(Ong’echa et al., manuscript submitted).  Reticulocyte production index (RPI) was 
derived as RI/maturation factor (MF), where MF = b + (m)(x), b = 1, m = 0.05, and x = 
(average normal population hematocrit – patient’s hematocrit) (Turgeon, 1993).  Our 
measurements of Hb levels and hematocrit values in age-matched healthy children in 
Siaya revealed a normal hemoglobin value of 12.0 g/dL and an average normal 
population hematocrit value of 36.0 (Ong’echa et al., manuscript submitted).  Thus, 
based on age- and geographically-matched normal Hb and hematocrit values obtained 
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from over 1000 children enrolled in this study, a hematocrit value of 36.0 was used to 
normalize the reticulocyte counts (Ong’echa et al., manuscript submitted).  This 
correction takes into account the increased shift in reticulocyte extravasation from the 
bone marrow (reticulocyte shift) in anemic patients and the dependence of reticulocyte 
maturation time on the degree of anemia (Clark and Hippel, 2002).  The percent of 
pigment-containing monocytes (% PCM) was calculated as the number of monocytes 
containing malarial pigment (hemozoin)/30 x 100, where 30 is the number of monocytes 
counted from a blood film.  
Based on Hb and parasitemia test results, children were placed into one of six 
clinical categories: Healthy Controls (HC), Hospitalized Controls (HosC), Uncomplicated 
Malaria (UM), Mild Malarial Anemia (MlMA), Moderate Malarial Anemia (MdMA), 
and Severe Malarial Anemia(SMA).  Anemia was defined as Hb < 11.0 g/dL, according 
to standard guidelines for children under 5 years of age in developing nations (Murray 
and Lopez, 1996).  The HC group included aparasitemic children with Hb ≥ 11.0 g/dL, 
no prior hospitalizations, and absence of fever or diarrhea in the last 14 days (Ong’echa 
et. al, 2006).  HosC included aparasitemic children with Hb < 11.0 g/dL, who were 
treated for non-malarial diseases.  Children with UM were defined as having parasitemia 
(P. falciparum) of any density, Hb < 11.0 g/dL, and no symptoms of severe malaria (such 
as hypoglycemia).  Children in the MlMA group had parasitemia of any density, 11.0 
g/dL > Hb ≥ 8.00 g/dL, and no symptoms of severe malaria.  MdMA subjects were 
defined by parasitemia of any density, 8.00 g/dL > Hb ≥ 6.00 g/dL, and no symptoms of 
severe malaria.  Children with SMA were defined as having parasitemia of any density 
and Hb < 6.00 g/dL.  Children with cerebral malaria and children who had received 
antimalarial treatment within two weeks prior to visiting the hospital were excluded from 
the study (Ong’echa et al., 2006).  Due to our particular interest in malarial anemia, the 
HosC group was excluded from these analyses. 
 
2.6    Multiplex Assay:  Plasma cytokine protein levels (IFN-α, IFN-γ, TNF-α, IL-1β, 
IL-2, IL-4, IL-6, IL-10, and IL-12p40/p70) of the study participants described above (n = 
189) were determined using the BioSource Human Cytokine 25-Plex Antibody Bead Kit 
(BioSource, International, Inc., Camarillo, CA).  The assay was performed according to 
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the manufacturers specifications, using the Luminex® 100™ System analyzer (Luminex 
Corporation, Austin, TX).  Briefly, wells of filter bottom microplates were pre-wetted 
with Working Wash Solution (200 μL) and then aspirated with a vacuum manifold. 
Followed by a second wash, incubation buffer (50 μL) was pipetted into the wells.  Beads 
(25 μL) of defined spectral properties conjugated to analyte-specific capture antibodies, 
standards (100 μL) of known analyte concentration, control samples (100 μL), and 
unknown (plasma) samples (100 μL) were pipetted into designated wells.  Standards, 
controls, and unknown samples were assayed in duplicate.  Plasma samples (50 μL) were 
centrifuged at 14,000 rpm (and/or filtered) and diluted 1:1 with Assay Diluent (50 μL) 
prior to addition to the wells.  Sealed, foil-wrapped plates were incubated at room 
temperature for 2 hrs on an orbital shaker, after which wells were aspirated and washed 
twice with Working Wash Solution (200 μL).  Following addition of analyte-specific 
Biotinylated Detector Antibody (100 μL) to each well, the plates were incubated at room 
temperature for 1 hr on an orbital shaker.  Wells were then aspirated and washed twice, 
before addition of Streptavidin-R-Phycoerythrin (100 μL/well).  After a 30-min 
incubation at room temperature on an orbital shaker, wells were aspirated, and the beads 
were washed three times.  100 μL of Working Wash Solution was dispensed to each well, 
and the plates were placed on an orbital shaker for 2-3 min to resuspend the beads.  
Analyte concentrations were determined by analyzing the spectral properties of the 
capture beads and the amount of associated R-Phycoerythrin fluorescence with a 
Luminex® 100™ instrument.  
 
2.7    Statistical Analyses:   Data were analyzed using the Minitab statistical program 
(Minitab Release 14 for Windows, Minitab, Inc.).  β-actin, TNF-α, IL-12A (p35), IL-12B 
(p40), IL-10, TGF-β1, IFN-α, IFN-γ, IL-2, IL-4, IL-6, IL-18, IL-1β, LT-α, NOS-2A, 
COX-1, and COX-2 mRNA transcripts were measured in duplicate.  Pairwise 
comparisons between conditions were performed using the paired Student’s t test, with 
statistical significance set at P < 0.05.  To adjust for multiple comparisons, a Bonferroni 
correction was applied, and P < 0.01 was considered statistically significant.   
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For Tables 1-4, multiple group comparisons were performed by Kruskal-Wallis 
tests, and differences between proportions were determined by Chi-square analysis.  
Pairwise analyses of UM vs. SMA groups (Table 3) were performed by Mann-Whitney U 
tests for variables that were significantly different by Kruskal-Wallis tests.  Statistical 
significance was set at P < 0.05 for all tests. 
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3.0    RESULTS 
 
Specific Aim 1: To determine the effect of naturally acquired Plasmodium falciparum 
hemozoin on hematological outcomes in infants and young children 
with malarial anemia 
 
3.1    Results:  Hematology and Malarial Pigment Data 
 
3.1.1    Clinical and laboratory parameters: 
   Due to the importance of elucidating the pathological effects of malarial pigment 
(hemozoin) on hematopoietic development and its role in malarial anemia (MA), we 
chose to examine hematological data obtained from healthy children and children with 
varying degrees of MA.  Study participants included infants and children aged 0-3 years 
from an area of holoendemic Plasmodium falciparum transmission (Siaya District, 
Nyanza Province, western Kenya) (Ong’echa et al., 2006).   These children were chosen 
as participants in the hospital-based study, since malaria is the primary cause of 
morbidity and mortality in African children in this age group (WHO, 2000).  
Furthermore, MA causes the majority of malaria-related morbidity and mortality among 
children less than five years of age (Breman et al., 2001; WHO, 2000).  In western 
Kenya, the prevalence of malaria in children 1-4 years of age is 83%, and the prevalence 
of anemia in children under 5 years of age ranges from 60-90% (Bloland et al., 1999; 
McElroy et al., 2000).  
   Heel/finger prick blood (< 100μL) was obtained from subjects to screen for 
hemoglobin (Hb) levels and parasitemia, and to perform complete blood counts. Based on 
Hb and parasitemia (P. falciparum) test results, children (n = 648) were placed into one 
of six clinical categories: Healthy Controls (HC), Hospitalized Controls (HosC), 
Uncomplicated Malaria (UM), Mild Malarial Anemia (MlMA), Moderate Malarial 
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Anemia (MdMA), and Severe Malarial Anemia (SMA).  Anemia was defined as Hb < 
11.0 g/dL, according to standard guidelines for children under 5 years of age in 
developing nations (Murray et al., 1996).  The HC group included aparasitemic children 
with Hb ≥ 11.0 g/dL, no prior hospitalizations, and absence of fever or diarrhea in the last 
14 days (Ong’echa et. al, 2006).  HosC included aparasitemic children with Hb < 11.0 
g/dL, who were treated for non-malarial diseases.  This group was excluded from the 
analyses, which focus on malarial anemia.  Children with UM were defined as having 
parasitemia of any density, Hb < 11.0 g/dL, and no symptoms of severe malaria (such as 
hypoglycemia).  Children in the MlMA group had parasitemia of any density, 11.0 g/dL 
> Hb ≥ 8.00 g/dL, and no symptoms of severe malaria.  MdMA subjects were defined by 
parasitemia of any density, 8.00 g/dL > Hb ≥ 6.00 g/dL, and no symptoms of severe 
malaria.  Children with SMA were defined as having parasitemia of any density and Hb < 
6.00 g/dL.   Multiple group comparisons were performed by Kruskal-Wallis tests, and 
differences between proportions were determined by Chi-square analysis, with statistical 
significance set at P < 0.05 for all tests.  
Table 1 summarizes the clinical and demographic characteristics of study 
participants (n = 648), stratified according to clinical category.  Specifically, leukocytic, 
erythrocytic, platelet, and parasitological indices were analyzed.  The distribution of 
study participants among the five clinical categories was as follows: HC, n = 63; UM, n = 
36; MlMA, n = 146; MdMA, n = 167; and SMA, n = 236.  Enrolled subjects included 
327 males and 314 females, and the proportion of males and females in the different 
clinical categories was not significantly different (P = 0.079).  Multiple group 
comparisons revealed that age was significantly associated with disease severity (P < 
0.0001).  Children in the HC group were the youngest, with a mean enrollment age of 
9.35 ± 0.85 months (mean ± SEM), followed by children with SMA (10.76 ± 0.45 
months).  Mean enrollment ages of subjects in the UM, MlMA, and MdMA categories 
were 12.24 ± 1.51, 12.87 ± 0.58, and 12.38 ± 0.53 months, respectively. Thus, among 
children with malaria, those with SMA were the youngest.  
Mean axillary temperature (°C) differed significantly among the clinical groups 
(P < 0.0001), but parasitemia was not significantly associated with disease severity (P = 
.358).  The UM group exhibited the highest mean parasitemia (76,737 ± 15,948/μL), 
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followed by those children in the SMA group (63,245 ± 6,148/μL).  The MdMA group 
had the lowest mean parasitemia (51,074 ± 5,638/μL).  High density parasitemia (HDP, ≥ 
10,000 parasites/μL) was also not significantly different among the groups (P = 0.764).  
The UM group contained the greatest proportion of subjects with HDP (77.78%), 
whereas the MdMA group contained the least (69.46%). 
In Table 1, all leukocyte indices [white blood cell (WBC), lymphocyte (LY), 
monocyte (MO), and granulocyte (GR) counts] were significantly associated with disease 
severity (P < 0.0001).  Mean WBC counts were highest in the SMA group (15.04 ± 0.57 
x103 cells/μL) and lowest in the MdMA group (11.65 ± 0.36 x103 cells/μL).  Children 
with SMA also had the highest mean lymphocyte (7.62 ± 0.31 x103 cells/μL) and 
monocyte counts (1.55 ± 0.06 x103 cells/μL), whereas those with UM had the lowest 
(4.82 ± 0.42 x103 and 0.76 ± 0.42 x103 cells/μL, respectively).  Mean granulocyte 
number (x103 cells/μL) was highest among those in the UM category (6.81 ± 0.60) and 
lowest among study participants in the HC group (3.96 ± 0.39). 
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       Table 1.  Clinical and demographic characteristics of study participants 
 
 HC UM MlMA MdMA SMA P 
       
No. of subjects 63 36 146 167 236  
Demographic Factors       
Age, mos. 9.35 (0.85) 12.24 (1.51) 12.87 (0.58) 12.38 (0.53) 10.76 (0.45) <0.0001a
Sex       
Female, n (%) 38 (60.32) 20 (58.82) 59 (40.97) 80 (48.48) 117 (49.79) 0.079b
Male, n (%) 25 (39.68) 14 (41.18) 85 (59.03) 85 (51.52) 118 (50.21)  
       
Clinical/Parasitological Factors       
Temperature, ˚C 36.77 (0.10) 37.66 (0.19) 37.60 (0.09) 37.73 (0.09) 37.56 (0.06) <0.0001a
Parasitemia, /μL 0 (0) 76,737 (15,948) 51,172 (5,091) 51,074 (5,638) 63,245 (6,148) 0.358c
HDP, n (%) 0 (0) 28 (77.78) 106 (72.60) 116 (69.46) 169 (71.61) 0.764d
       
Leukocytic Factors       
WBC, x103 cells/μL 11.88 (0.57) 12.39 (0.72) 11.65 (0.36) 12.02 (0.39) 15.04 (0.57) <0.0001a
LY, x103 cells/μL 7.05 (0.38) 4.82 (0.42) 5.52 (0.23) 6.03 (0.22) 7.62 (0.31) <0.0001a
MO, x103 cells/μL 0.89 (0.05) 0.76 (0.07) 0.96 (0.05) 1.12 (0.05) 1.55 (0.06) <0.0001a
GR, x103 cells/μL 3.96 (0.39) 6.81 (0.60) 5.17 (0.24) 4.88 (0.24) 5.87 (0.29) <0.0001a
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       Table 1 Continued.   
 
 HC UM MlMA MdMA SMA P 
Erythrocytic Factors       
RBC, x106 cells/ μL 5.01 (0.07) 4.72 (0.12) 4.17 (0.06) 3.20 (0.05) 2.21 (0.04) <0.0001a
Hb, g/dL 11.70 (0.07) 11.68 (0.14) 9.28 (0.07) 6.85 (0.05) 4.80 (0.06) <0.0001a
Hct, % 35.51 (0.25) 34.26 (0.86) 28.19 (0.30) 21.81 (0.19) 15.35 (0.22) <0.0001a
RPI < 2 0.82 (0.06) 0.86 (0.08) 0.62 (0.03) 0.74 (0.04) 0.76 (0.04) 0.021a
RPI ≥ 3 5.16 (1.15) 6.40 (2.40) - 3.59 (0.36) 4.07 (0.30) 0.168a
MCV, fL 71.32 (0.74) 73.10 (1.21) 68.39 (0.63) 69.43 (0.74) 71.42 (0.66) 0.002a
MCH, pg/cell 23.54 (0.29) 24.30 (0.43) 22.26 (0.24) 21.94 (0.26) 22.45 (0.23) <0.0001a
MCHC, g/dL 32.97 (0.13) 33.19 (0.21) 32.51 (0.13) 31.61 (0.14) 31.43 (0.15) <0.0001a
RDW, %  16.71 (0.43) 17.08 (0.51) 19.31 (0.27) 22.17 (0.26) 23.27 (0.28) <0.0001a
       
Platelet Factors       
Plt, x103 cells/ μL 432.57 (20.18) 239.69 (20.15) 203.54 (11.34) 175.62 (7.96) 165.31 (6.10) <0.0001a
MPV, fL 7.40 (0.12) 7.81 (0.20) 8.37 (0.12) 8.66 (0.10) 8.71 (0.09) <0.0001a
Pct, % 0.32 (0.01) 0.18 (0.01) 0.17 (0.01) 0.15 (0.01) 0.14 (0.01) <0.0001a
PDW, % 16.95 (0.12) 17.01 (0.17) 17.23 (0.08) 17.61 (0.09) 17.71 (0.10) <0.0001a
 
Values represent mean (SEM) unless otherwise noted. 
aMultiple group comparisons  were analyzed by Kruskal-Wallis tests. 
bChi-square analysis was performed for multiple group comparisons of proportions. 
cMultiple group comparisons were analyzed by Kruskal-Wallis tests and included all parasitemic groups. 
dChi-square analysis was performed for multiple group comparisons of proportions and included all parasitemic groups. 
 
Abbreviations:  HC, healthy controls; UM, uncomplicated malaria; MlMA, mild malarial anemia; MdMA, moderate malarial anemia; SMA, severe malarial 
anemia; Parasitemia, parasites/μL; HDP, high density parasitemia (≥ 10,000 parasites/μL); Hb, hemoglobin concentration; RPI, reticulocyte production index; 
WBC, white blood cell; LY, lymphocyte count; MO, monocyte count; GR, granulocyte count; RBC, red blood cell count; Hct, hematocrit (relative volume of 
erythrocytes); MCV, mean corpuscular (erythrocyte) volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, 
red cell (erythrocyte volume) distribution width; Plt, platelet/thrombocyte count; MPV, mean platelet(thrombocyte) volume; Pct, plateletcrit; PDW, platelet 
distribution width. 
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All erythrocyte parameters were significantly different among clinical categories 
at P < 0.0001, with the exception of mean corpuscular volume (MCV), which was 
significant at P = 0.002.  The mean hemoglobin (Hb, g/dL) concentrations for the groups 
were 11.70 ± 0.07 (HC), 11.68 ± 0.14 (UM), 9.28 ± 0.07 (MlMA), 6.85 ± 0.05 (MdMA), 
and 4.80 ±  0.06 (SMA).  As expected, mean red blood cell (RBC) counts (x106 cells/μL) 
were highest in the HC group (5.01 ± 0.07) and lowest in the SMA category (2.21 ± 
0.04).  In agreement with this finding, mean hematocrit (Hct, %) was highest among 
healthy controls (35.51 ± 0.25) and lowest among children with SMA (15.35 ± 0.22).  
Reticulocyte production index (RPI), which is a function of reticulocyte maturation time 
and dependent on the degree of anemia (Clark and Hippel, 2002), was stratified as RPI < 
2 or RPI ≥ 3.  A reticulocyte production index less than 2 (RPI < 2), indicative of an 
inadequate bone marrow proliferative response or ineffective erythropoiesis, differed 
significantly among HC, UM, MlMA, MdMA, and SMA groups (P = 0.021).  An RPI 
less than 2 was lowest in children with mild MA (0.62 ± 0.03) and highest among those 
with uncomplicated malaria (0.86 ± 0.08).  A reticulocyte production index greater than 
or equal to 3 (RPI ≥ 3), which indicates an erythropoietic response appropriate for the 
degree of anemia, was not significantly different between clinical categories (P = 0.168).  
MCV (mean corpuscular/erythrocyte volume, fL) correlated with RPI, being lowest in the 
MdMA category (68.39 ± 0.63) and highest in the UM category (73.10 ± 1.21).  Mean 
corpuscular hemoglobin (MCH, pg/cell) was greatest in the UM group and lowest in the 
MdMA group.  Mean corpuscular hemoglobin concentration (MCHC, g/dL) was also 
highest in the UM group, but lowest in children with SMA.  Red cell distribution width 
(RDW, %), which represents the coefficient of variation of the RBC size, was lowest in 
HC subjects (16.71 ± 0.43) and highest in the SMA group (23.27 ± 0.28).   
Platelet indices were also significantly different among the clinical categories (P 
< 0.0001), with the most extreme values occurring between the HC and SMA groups.  
The HC group had the highest mean platelet counts (432.57 ± 20.18 x103 cells/μL) and 
mean plateletcrit (0.32 ± 0.01%), and the SMA group had the lowest (165.31 ± 6.10 and 
0.14 ±0.01, respectively).  Conversely, mean platelet volume (MPV, fL) was highest in 
the SMA clinical category (8.71 ± 0.09) and lowest in healthy control subjects (7.40 ± 
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0.12).  Platelet distribution width (PDW, %), which represents the coefficient of variance 
of platelet size, was highest in the SMA group (17.71 ± 0.10) and lowest in healthy 
children (16.95 ± 0.12). 
Table 2 summarizes the clinical and demographic characteristics of parasitemic 
study participants (UM, MlMA, MdMA, and SMA groups, n = 555), stratified according 
to percent of pigment-containing monocytes (% PCM).  Children were grouped as such, 
since the presence of intraleukocytic pigment is a useful prognostic indicator of severe 
malaria infection after clearance of parasites from the peripheral blood (Phu et al., 1994; 
Day et al., 1996).  Furthermore, hemozoin is present in the peripheral blood phagocytes 
of  > 90% of patients with severe malaria (Day et al., 1996). 
Monocyte pigment categories were designated as 0% PCM, ≤ 10% PCM, and > 
10% PCM.  Distribution of study participants among the different pigment categories was 
as follows:  0% PCM, n = 284; ≤ 10% PCM, n = 110; and > 10% PCM, n = 161.  The 
proportion of males and females in each group was not significantly different (P = 0.068).  
Multiple group comparisons showed that age was not significantly associated with blood 
content of pigment-containing monocytes (P = 0.216), though children with > 10% PCM 
were the youngest (11.15 ± 0.54 months).  Mean axillary temperature (°C) was 
significantly different among pigment categories (P = 0.034).  Parasitemia was 
significantly associated (P = 0.002) with percent of pigment-containing monocytes and 
increased with increasing % PCM.  The > 10% PCM group contained subjects with the 
highest mean parasitemia (76,133 ± 7,983 parasites/μL), followed by the ≤ 10% and 0% 
PCM groups (56,348 ± 7,505 and 45,337 ± 3,532, respectively).  However, the ≤ 10% 
PCM group contained the greatest proportion of subjects with HDP (78%), which also 
differed significantly between groups (P = 0.032). 
 All leukocyte indices were significantly different between pigment categories (P 
< .0001), with the exception of granulocyte count (P = 0.441).  WBC, lymphocyte, and 
monocyte counts increased with the percent of pigment-containing monocytes. 
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Table 2.  Clinical and demographic characteristics of parasitemic study participants stratified according to percent of pigment-
containing monocytes 
 
Monocyte Pigment Categories 0% ≤ 10% > 10% P 
     
No. of subjects 284 110 161  
     
Demographic Factors     
Age, mos. 12.17 (0.41) 12.44 (0.74) 11.15 (0.54) 0.216a
Sex     
   Female, n (%)     123 (43.62) 62 (56.36) 83 (51.88) 0.068b
    Male, n (%) 159 (56.38) 48 (43.64) 77 (48.13)  
     
Clinical/Parasitological Factors     
Temperature, ˚C 37.74 (0.07) 37.60 (0.10) 37.44 (0.08) 0.034a
Parasitemia, /μL 45,337 (3,532) 56,348  (7,505) 76,133 (7,983) 0.002a
HDP, n (%) 192 (67.61) 86 (78.00) 124 (77.00) 0.032b
     
Leukocytic Factors     
WBC, x103 cells/μL 12.17 (0.35) 12.92 (0.60) 14.95 (0.66) <0.0001a
LY, x103 cells/μL 5.82 (0.21) 6.52 (0.37) 7.46 (0.33) <0.0001a
MO, x103 cells/μL 1.07 (0.04) 1.22 (0.08) 1.49 (0.07) <0.0001a
GR, x103 cells/μL 5.29 (0.18) 5.19 (0.34) 6.00 (0.37) 0.441a
     
Erythrocytic Factors     
RBC, x106 cells/ μL 3.54 (0.06) 2.90 (0.09) 2.64 (0.07) <0.0001a
Hb, g/dL 7.77 (0.13) 6.57 (0.20) 5.83 (0.16) <0.0001a
%SMA, n (%) 64 (22.54) 56 (50.91) 99 (61.49) <0.0001b
Hct, % 24.05 (0.39) 20.30 (0.58) 18.23 (0.49) <0.0001a
RPI < 2 0.80 (0.03) 0.71 (0.05) 0.69 (0.04) 0.023a
RPI ≥ 3 3.96 (0.20) 4.01 (0.41) 4.99 (1.44) 0.862a
MCV, fL 69.21 (0.55) 71.27 (0.94) 70.21 (0.67) 0.103a
MCH, pg/cell 22.21 (0.20) 22.62 (0.32) 22.44 (0.25) 0.407a
MCHC, g/dL 32.06 (0.11) 31.73 (0.17) 31.96 (0.16) 0.243a
RDW, % 21.17 (0.26) 21.96 (0.41) 22.09 (0.30) <0.006a
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Table 2 Continued.   
 
Monocyte Pigment Categories 0% ≤ 10% > 10% P 
     
Platelet Factors     
Plt, x103 cells/ μL 201.87 (7.21) 164.01 (8.52) 156.78 (6.26) <0.0001a
Pct, % 8.34 (0.08) 8.61 (0.14) 8.90 (0.11) <0.0001a
MPV, fL 0.17 (0.01) 0.14 (0.01) 0.14 (0.01) 0.004a
PDW, % 17.44 (0.07) 17.42 (0.10) 17.74 (0.08) 0.014a
     
 
 
Values represent mean (SEM) unless otherwise noted. 
aMultiple group comparisons were analyzed by Kruskal-Wallis tests. 
bChi-square analysis was performed for multiple group comparisons of proportions. 
 
Abbreviations: Parasitemia, parasites/μL; HDP, high density parasitemia (≥ 10,000 parasites/μL); Hb, hemoglobin concentration; 
%SMA, percent severe malarial anemia; RPI, reticulocyte production index; WBC, white blood cell; LY, lymphocyte count; MO, 
monocyte count; GR, granulocyte count; RBC, red blood cell count; Hct, hematocrit (relative volume of erythrocytes); MCV, mean 
corpuscular (erythrocyte) volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, 
red cell (erythrocyte volume) distribution width; Plt, platelet/thrombocyte count; MPV, mean platelet(thrombocyte) volume; Pct, 
plateletcrit; PDW, platelet distribution width. 
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  Among erythrocyte indices, RBC count, Hb, and hematocrit were significantly 
different (P < 0.0001) between pigment categories.  The 0% PCM category contained 
children having the highest RBC counts (3.54 ± 0.06 x106 cells/μL), Hb (7.77 ± 0.13 
g/dL), and hematocrit (24.05 ± 0.39 %), whereas the > 10% PCM category contained 
children with the lowest (2.62 ± 0.07 x106 cells/μL, 5.83 ± 0.16 g/dL, and 18.23 ± 0.49 
%, respectively).  Notably, the percent of study participants diagnosed with SMA was 
significantly different among PCM categories (P < 0.0001), and the greatest proportion of 
children with SMA (61.49%) were included in the > 10% PCM group.  RPI < 2 
(suppression of erythropoiesis) was significantly associated with pigment category (P = 
.023), decreasing with increasing % PCM.  RPI ≥ 3 (appropriate erythropoietic response 
for the degree of anemia) did not differ significantly between pigment categories.  Taken 
together, these results demonstrate that percent of pigment-containing monocytes may be 
predictive of the severity of MA.  However, erythrocytic factors that were not 
significantly associated with pigment category included MCV (P = 0.103), MCH (P = 
0.407), and MCHC (P = 0.243).  RDW was significantly different between groups (P = 
0.006) and increased with increasing % PCM. 
 In addition, all platelet indices were significantly different among monocyte 
pigment categories.  Mean platelet count (P < 0.0001) was inversely associated with 
percent of pigment-containing monocytes.  Mean platelet volume (P < 0.0001) increased 
with increasing % PCM.  Plateletcrit (P = 0.004) was highest in the 0% PCM category 
and equivalent in the ≤ 10% PCM and > 10% PCM categories.  Platelet distribution width 
(P = 0.014) was greatest in the > 10% pigment group (17.74 ± 0.08).    
  
In summary, results presented in Tables 1 and 2 indicate that monocytic 
acquisition of hemozoin is significantly associated with hematological parameters in 
children with varying severities of malarial anemia.  Leukocyte, erythrocyte, and platelet 
indices were significantly different between HC, UM, MlMA, MdMA, and SMA clinical 
groups.  The majority of leukocyte, erythrocyte, and platelet indices were also 
significantly different between pigment-containing monocyte categories.  Temperature 
was significantly associated with clinical category and with proportion of pigment-
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containing monocytes.    Age was significantly different between clinical groups but not 
between PCM categories.  However, among children with malaria, those with SMA and 
those with > 10% pigment-containing monocytes were the youngest.  Parasitemia (/μL) 
and high density parasitemia (%) were significantly associated with proportion of 
pigment containing monocytes but not with clinical group.  Suppression of 
erythropoiesis, as indicated by a reticulocyte production index less than 2, was greatest 
(lowest RPI) in children with mild MA (Table 1) and in those children with the greatest 
proportion (> 10%) of pigment-containing monocytes (Table 2).  Children in the > 10% 
pigment-containing monocyte group exhibited the lowest Hb, hematocrit, and erythrocyte 
counts.  In addition, the > 10% PCM group contained the greatest proportion of children 
with SMA.  Taken together, these results suggest that the development of SMA is 
mediated, at least in part, by the phagocytosis of hemozoin by monocytes.  Of relevance, 
malarial immunity is defined by concomitant interactions between a large number of 
different innate inflammatory mediators, and ingestion of hemozoin by peripheral blood 
mononuclear cells promotes dysregulation of inflammatory mediator production in 
children with malaria.  Since these measurements have not been performed previously in 
children with malaria, we decided to measure numerous innate inflammatory mediators in 
children with varying severities of malarial anemia using a cytokine multiplex assay. 
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Specific Aim 2: To determine the relationship between in vivo innate inflammatory 
mediator production and monocytic acquisition of Plasmodium 
falciparum hemozoin in infants and young children with malarial 
anemia    
 
3.2    Results:  Multiplex Assay 
 
3.2.1    Clinical and laboratory parameters: 
In order to compare cytokine protein levels among children with (and without) 
varying degrees of malarial anemia (MA), plasma levels of IL-12p40/p70, IFN-α, IFN-γ, 
TNF-α, IL-1β, IL-2, IL-4, IL-6, and IL-10 from study participants described previously 
(n = 189) were determined by multiplex assay.  Plasma cytokine levels of parasitemic 
study participants (UM, MlMA, MdMA, and SMA groups) were further stratified 
according to blood content of pigment-containing monocytes to examine whether 
cytokine production was positively correlated with percent of pigment-containing 
monocytes (% PCM).  Multiple group comparisons were performed by Kruskal-Wallis 
tests, with statistical significance set at P < 0.05 for all analyses.  Due to our interest in 
understanding the role of these cytokines in mediating the development of uncomplicated 
versus severe disease (anemia), pairwise comparisons of UM versus SMA groups were 
performed by Mann-Whitney U tests for variables that were significantly different by 
Kruskal-Wallis tests. 
Table 3 illustrates the plasma cytokine profiles of study participants, stratified by 
clinical category (HC, n = 34; UM, n = 20; MlMA, n = 38; MdMA, n = 13; and SMA, n 
= 84).  Multiple group comparisons revealed that plasma levels (pg/mL) of IFN-γ (P = 
0.138), TNF-α (P = 0.465), IL-1β (P = 0.816), and IL-2 (P = 0.673) were not 
significantly different between clinical groups.  Plasma IFN-α was significantly different 
among clinical categories (P < 0.0001).  The HC group had the highest mean (mean ± 
SEM) IFN-α levels (93.71 ± 14.95), and those subjects with moderate MA had the lowest 
IFN-α levels (9.97 ± 4.04).  Pairwise comparison of UM (43.77 ± 12.63) versus SMA 
(71.56 ± 32.47) groups showed that mean plasma IFN-α levels were not significantly 
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different (P = 0.586) between the groups.  Mean plasma levels of IL-4 and IL-6 were 
significantly different among clinical categories (P = 0.004 and P < 0.0001, respectively).  
Consistent with IFN-α levels, plasma IL-4 was highest among healthy controls (34.26 ± 
8.53) and lowest in the MdMA group (4.68 ± 1.16).  Pairwise comparison of UM (10.42 
± 2.72) versus SMA (13.17 ± 2.15) groups indicated that plasma IL-4 levels were not 
significantly different between these clinical categories (P = 0.745).  Plasma IL-6 levels 
were highest in children with severe malarial anemia (273.09 ± 56.64) and lowest in 
healthy control subjects (56.24 ± 13.06), but were not significantly different (P = 0.289) 
between UM and SMA groups.  Study participants with uncomplicated malaria had the 
highest plasma levels of IL-10 (978.82 ± 478.34), which were determined to be 
significantly different among clinical groups (P < 0.0001).  The HC group contained 
those subjects with the lowest levels of IL-10 (118.03 ± 24.82).  However, pairwise 
comparison of UM versus SMA clinical groups revealed that plasma IL-10 levels were 
not significantly different (P = 0.539) between the two groups.  Plasma IL-12p40/p70 
also differed significantly among clinical categories (P = 0.009).  Children in the MlMA 
group had the highest levels of IL-12p40/p70 (564.68 ± 69.93), whereas plasma IL-
12p40/p70 was lowest among those with moderate malarial anemia (309.18 ± 32.91).  IL-
12 levels were not significantly different between UM and SMA clinical categories (P = 
0.911). 
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Table 3.  Plasma cytokine levels of study participants 
 
 HC UM MlMA MdMA SMA P P (UM vs. SMA) 
        
No. of subjects 34 20 38 13 84   
        
Cytokine  (pg/mL)        
IFN-α 93.71 (14.95) 43.77 (12.63) 52.42 (13.47) 9.97 (4.04) 71.56 (32.47) <0.0001a 0.568b
IFN-γ 35.22 (7.28) 46.36 (20.59) 18.93 (5.58) 15.46 (5.06) 19.09 (4.50) 0.138a  
TNF-α 103.45 (57.48) 36.18 (7.19) 54.85 (12.48) 27.23 (7.63) 48.77 (5.26) 0.465a  
IL-1β 300.08 (73.63) 169.25 (46.17) 278.59 (71.67) 272.67 (86.68) 234.57 (28.77) 0.816a  
IL-2 117.52 (39.31) 41.03 (14.08) 114.53 (52.12) 81.67 (38.36) 90.91 (32.18) 0.673a  
IL-4 34.26 (8.53) 10.42 (2.72) 17.89 (7.14) 4.68 (1.16) 13.17 (2.15) 0.004a 0.745b
IL-6 56.24 (13.06) 159.95 (53.96) 248.23 (65.10) 121.37 (48.26) 273.09 (56.64) <0.0001a 0.289b
IL-10 118.03 (24.82) 978.82 (478.34) 926.72 (253.57) 302.40 (103.82) 538.96 (76.16) <0.0001a 0.539b
IL-12p40/p70 557.39 (59.51) 400.48 (45.81) 564.68 (69.93) 309.18 (22.91) 418.95 (26.73) 0.009a 0.911b
        
 
Values represent mean (SEM) unless otherwise noted. 
aMultiple group comparisons were analyzed by Kruskal-Wallis tests. 
bPairwise analyses of UM vs. SMA groups were performed by Mann-Whitney U tests for variables that were significantly different by Kruskal-Wallis tests. 
 
Abbreviations:  HC, healthy controls; UM, uncomplicated malaria; MlMA, mild malarial anemia; MdMA, moderate malarial anemia; SMA, severe malarial 
anemia. 
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 Table 4 summarizes the plasma cytokine protein levels of parasitemic study 
participants (UM, MlMA, MdMA, and SMA groups; n = 155), stratified according to 
percent of pigment-containing monocytes (0%, ≤ 10%, and > 10%).  Distribution of study 
participants among the three pigment categories was as follows:  0% PCM, n = 73; ≤ 
10% PCM, n = 32; and > 10% PCM, n = 50.  Multiple group comparisons showed that 
when subjects were grouped according to percent of pigment-containing monocytes (% 
PCM), mean plasma levels of IFN-γ (P = 0.211), IL-1β (P = 0.761), and IL-2 (P = 0.509) 
were not significantly different among pigment categories.  Plasma IFN-γ was lowest 
among children in the ≤ 10% PCM category and highest among those with 0% pigment-
containing monocytes.  Relative to IL-1β levels of subjects with 0% pigment-containing 
monocytes, plasma IL-1β was elevated in the ≤ 10% PCM group and suppressed in the > 
10% PCM group.  Children with 0% pigment-containing monocytes exhibited the lowest 
levels of IL-2, whereas children in the ≤ 10% PCM category had the highest levels of IL-
2.   
Although IFN-α, IL-4, IL-6, IL-10 and IL-12p40/p70 levels had been determined 
to differ significantly between clinical groups (Table 3), these cytokines were also not 
significantly associated with the proportion of pigment-containing monocytes (P = 0.579, 
P = 0.300, P = 0.542, and  P = 0.172, respectively).  Mean plasma IFN-α and IL-4 were 
highest among children in the > 10% PCM category and lowest in the ≤ 10% PCM group.  
Relative to children with 0% pigment-containing monocytes, those in the ≤ 10% PCM 
category had elevated levels of IL-6 and IL-12p40/p70, and those in the > 10% PCM 
category exhibited decreased levels of IL-6 and IL-12p40/p70.  Plasma levels of IL-10 
were inversely associated with proportion of pigment-containing monocytes.   
Differences in plasma TNF-α between pigment-containing monocyte categories 
bordered statistical significance at P = 0.051.  Parasitemic children in the ≤ 10% PCM 
group exhibited the highest levels (pg/mL) of TNF-α (61.42 ± 13.06), whereas those with 
0% PCM had the lowest plasma TNF-α (39.92 ± 6.21). 
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Table 4.  Plasma cytokine levels of parasitemic study participants stratified according to percent of pigment-containing 
monocytes 
 
Monocyte Pigment Categories 0% ≤ 10% > 10% P 
     
No. of subjects 73 32 50  
     
Cytokine  (pg/mL)     
IFN-α 45.22 (9.62) 32.04 (9.06) 93.64 (53.67) 0.579a
IFN-γ 26.60 (6.62) 9.72 (3.14) 23.97 (6.91) 0.211a
TNF-α 39.92 (6.21) 61.42 (13.06) 47.57 (5.28) 0.051a
IL-1β 239.54 (32.00) 300.48 (89.98) 202.35 (25.12) 0.761a
IL-2 69.07 (12.69) 131.15 (65.01) 92.64 (50.67) 0.509a
IL-4 13.79 (3.83) 9.27 (2.16) 15.04 (3.29) 0.300a
IL-6 228.35 (48.66) 342.13 (118.02) 190.61 (37.63) 0.221a
IL-10 835.29 (195.56) 611.96 (108.12) 468.73 (74.69) 0.542a
IL-12p40/p70 454.50 (37.00) 502.20 (58.61) 388.60 (33.45) 0.172a
     
 
Values represent mean (SEM) unless otherwise noted. 
aMultiple group comparisons were analyzed by Kruskal-Wallis tests. 
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 Taken together, results presented in Tables 3 and 4 demonstrate that plasma levels 
of IFN-α, IL-4, IL-6, IL-10, and IL-12p40/p70 are significantly different among HC, 
UM, MlMA, MdMA, and SMA clinical categories.  Differences in plasma levels of these 
inflammatory mediators between children with uncomplicated malaria and children with 
severe MA are not statistically significant.  Furthermore, among parasitemic children, 
plasma IFN-α, IL-4, IL-6, IL-10, and IL-12p40/p70 are not significantly associated with 
percent of pigment-containing monocytes.  Differences in plasma TNF-α are not 
significant between clinical groups but approach statistical significance between 0%, ≤ 
10%, and > 10% PCM categories.  Mean plasma levels of IFN-γ, IL-1β, and IL-2 are not 
significantly different among clinical groups or pigment-containing monocyte categories.   
In summary, stratification of children according to the proportion of pigment-
containing monocytes revealed distinct patterns of cytokine production that differed 
substantially for the different inflammatory mediators.  In children with and without 
varying degrees of malarial anemia, hemozoin produced a dose-response effect on plasma 
cytokine levels, differentially up-regulating production of some inflammatory mediators 
while down-regulating production of others.  These results suggest that malarial pigment 
plays an important role in promoting changes in cytokine production during malaria 
infection which contribute to the development of severe malarial anemia.  Importantly, 
malarial immunity is determined by concomitant interactions between numerous innate 
inflammatory mediators, and the role of hemozoin in regulating the temporal kinetics of 
cytokine production has not been previously investigated concomitantly for a large 
number of innate immune response genes.  For this reason, we next sought to determine 
the temporal kinetics of several innate immune response genes thought to be important 
mediators of the pathogenesis of malarial anemia.                             
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 Specific Aim 3: To determine the temporal kinetics of hemozoin-induced 
dysregulation in innate inflammatory mediators in cultured human 
peripheral blood mononuclear cells 
 
3.3    Results:  Quantitative Real Time RT-PCR 
 
3.3.1    Laboratory parameters: 
PBMC isolated from malaria-nave donors (n = 9) were stimulated with media 
alone or a high dose of β-hematin (10 μg/mL), and cells were harvested at 4, 8, 24, 48, 
and 72 hrs.  To investigate the temporal effect of β-hematin on de novo cytokine 
transcription, RNA was extracted from cells and reverse transcribed for real time RT-
PCR analysis.  Results are expressed as fold change ± SEM relative to control (media 
alone) conditions.  Statistical significance of the difference in means between baseline 
and stimulated conditions or between fold change at each time point and 4 hrs (time zero) 
was determined by paired t-tests.  P < 0.05 was considered statistically significant for 
stimulated versus control conditions.  To adjust for multiple comparisons of fold change 
at 8, 24, 48, and 72 hrs relative to fold change at 4 hrs, a Bonferroni correction was 
applied, and P < 0.01 was deemed statistically significant.   
 
3.3.2    Pro-inflammatory mediator production 
 
3.3.2.1    Temporal effect of β-hematin on IL-1β transcripts: 
IL-1β mRNA was detectable in stimulated cells at 4 hrs and continued to increase  
at 8 and 24 hrs (Figure 4).   The difference in means between transcript production under 
stimulated versus baseline conditions was statistically significant at all time points 
(indicated by asterisks).  In the majority of donors, transcript production peaked at 48 hrs, 
as evidenced by a > 300- to 1300-fold increase relative to untreated cells.  β-hematin 
significantly augmented donor 5 IL-1β mRNA at 24 hrs, producing a > 2400-fold 
increase over unstimulated conditions.  By 72 hrs, IL-1β transcripts began to decrease to 
levels below 600-fold over baseline.  Relative to the 4 hr time point (time zero), IL-1β 
mRNA production was significantly elevated at 48 (P = 0.001) and 72 hrs (P = 0.003). 
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Figure 4.  Temporal effect of β-hematin on IL-1β transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IL-1β mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.2    Temporal effect of β-hematin on IL-2 transcripts: 
   In the presence of β-hematin, IL-2 transcript production at 4, 8, and 24 hrs 
fluctuated at or slightly above baseline levels in most donors (Figure 5).  IL-2 mRNA 
increased between 24 and 48 hrs, peaking in the majority of subjects at 48 hrs.  Donors 6 
and 9 exhibited a sharp increase in IL-2 transcript production at 8 (> 18-fold) and 24 hrs 
(> 17-fold), respectively.  The difference in means between IL-2 transcript production 
under stimulated versus control conditions was statistically significant (P < 0.05) only at 
48 hrs.  IL-2 mRNA decreased by 72 hrs in 5 of 9 donors.  After correcting for multiple 
comparisons, it was determined that fold change in IL-2 was not significantly augmented 
at any subsequent time point, relative to 4 hrs. 
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Figure 5.  Temporal effect of β-hematin on IL-2 transcripts.  PBMC were isolated from venous blood (70 
mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IL-2 mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.3    Temporal effect of β-hematin on IL-6 transcripts: 
   Relative to baseline conditions, mean IL-6 transcript production in cells 
stimulated with a high dose of β-hematin was statistically significant at all time points 
(Figure 6).  IL-6 mRNA peaked in the majority of subjects at 24 hrs, reaching levels > 12 
to 1300 times those measured in unstimulated cells.  Fold change in IL-6 transcript 
production increased significantly between 4 and 48 hrs (P = 0.008).  β-hematin-induced 
IL-6 mRNA production decreased in 8 of 9 donors by 72 hrs. 
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Figure 6.  Temporal effect of β-hematin on IL-6 transcripts.  PBMC were isolated from venous blood (70 
mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IL-6 mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
 
3.3.2.4    Temporal effect of β-hematin on IL-12p35 transcripts: 
   After 4 hrs in culture, cells stimulated with β-hematin produced IL-12p35 
transcripts at near baseline levels (Figure 7).  IL-12p35 mRNA synthesis began to 
increase by 8 hrs post-stimulation, peaking at 72 hrs in most donors.  Fold change over 
unstimulated conditions was statistically significant at 24, 48, and 72 hrs.  Relative to 
fold change at 4 hrs, a significant increase in β-hematin-induced IL-12p35 transcript 
production occurred by 72 hrs post-stimulation (P = 0.006). 
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Figure 7.  Temporal effect of β-hematin on IL-12p35 transcripts.  PBMC were isolated from venous 
blood (70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for IL-12p35 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.5    Temporal effect of β-hematin on IL-12p40 transcripts: 
   In the presence of β-hematin, IL-12p40 mRNA was detectable in most subjects at 
4 hrs (Figure 8).  Peak IL-12p40 transcript production occurred at 24 hrs post-stimulation 
in the majority of donors and varied markedly in magnitude (> 4- to 850-fold over 
unstimulated cells).  IL-12p40 mRNA decreased by 48 hrs and continued to decrease at 
72 hrs in 8 of 9 subjects.  Donor 7 IL-12p40 transcript production peaked at 4 hrs and 
fluctuated over the course of 72 hrs.  Mean fold change in IL-12p40 transcript production 
under stimulated versus baseline conditions was statistically significant at all time points 
(P < 0.05).  
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Figure 8.  Temporal effect of β-hematin on IL-12p40 transcripts.  PBMC were isolated from venous 
blood (70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for IL-12p40 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.6    Temporal effect of β-hematin on IL-18 transcripts: 
   Fold change in β-hematin-induced IL-18 transcript production was statistically 
significant (P < 0.05) at 4 hrs post-stimulation (Figure 9).  Peak IL-18 mRNA production 
was divided among donors between 4 and 8 hrs. Whereas peak transcript production 
ranged from levels slightly above baseline to approximately 6-fold over control in most 
subjects, donor 6 exhibited a > 57-fold change in IL-18 mRNA.  With the exception of 
one donor, IL-18 transcripts decreased by 24 hrs and were suppressed from this time 
onward. 
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Figure 9.  Temporal effect of β-hematin on IL-18 transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IL-18 mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.7    Temporal effect of β-hematin on IFN-α transcripts: 
   β-hematin-induced IFN-α mRNA was detectable near baseline levels at 4 hrs in 
most subjects and fluctuated above and below baseline throughout the time course 
(Figure 10).  Peak transcript production was distributed among the five time points but 
occurred at 48 hrs in the majority of donors (3).  While most subjects showed a 2- to 13-
fold increase in IFN-α mRNA at peak transcript production, donor 9 exhibited a > 120-
fold increase in IFN-α mRNA.  The difference in means between IFN-α transcript 
production under stimulated versus baseline conditions was statistically significant at 48 
hrs post-challenge (P < 0.05). 
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Figure 10.  Temporal effect of β-hematin on IFN-α transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IFN-α mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.8    Temporal effect of β-hematin on IFN-γ transcripts: 
   β-hematin produced IFN-γ mRNA expression patterns that varied significantly 
among donors (Figure 11).  IFN-γ transcripts were detectable at 4hrs post-stimulation and 
fluctuated over time.  Peak transcript production occurred at 24 hrs in the majority of 
subjects (3) but was observed at 4, 8, 48, and 72 hrs, as well.  Peak levels of IFN-γ 
mRNA ranged from 4 to 22 times those measured in unstimulated cells.  Fold change in 
IFN-γ mRNA was statistically significant at 4, 24, and 72 hrs.   
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Figure 11.  Temporal effect of β-hematin on IFN-γ transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for IFN-γ mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.9    Temporal effect of β-hematin on TNF-α  transcripts: 
   After 4  hrs in culture, cells stimulated with β-hematin produced a 3- to 10-fold 
increase in TNF-α transcripts (Figure 12).  In most subjects, mRNA expression continued 
to increase at 8 hrs post-challenge, peaking at levels > 3- to 14-fold over baseline.  TNF-
α mRNA decreased by 24hrs and peaked slightly at 48 hrs in 5 of 9 donors.   By 72 hrs, 
TNF-α transcripts had decreased to levels < 3-fold over baseline.  Fold change in β-
hematin-induced TNF-α production was statistically significant at all time points (P < 
0.01). 
 
 
 
 
 
43 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
4hrs 8hrs 24hrs 48hrs 72hrs
Time (hrs)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
1
2
3
4
5
6
7
8
9
**
**
**
**
**
**P < 0.01
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
TN
F-
αm
R
N
A
 
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Temporal effect of β-hematin on TNF-α transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for TNF-α mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.10    Temporal effect of β-hematin on LT-α transcripts: 
    At 4 hrs, β-hematin induced LT-α mRNA at levels slightly above baseline 
(Figure 13).  LT-α transcripts increased gradually over time, peaking in 7 of 9 donors at 
72 hrs.  Peak mRNA expression was measured at levels > 2 to 8 times those observed in 
unstimulated cells.  The difference in means between LT-α mRNA expression under 
stimulated versus baseline conditions was statistically significant at all time points (P < 
0.01).  Relative to fold change at 4 hrs, fold change in LT-α mRNA increased 
significantly at 48 (P = 0.007) and 72 hrs (P = 0.001).  
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Figure 13.  Temporal effect of β-hematin on LT-α transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were stimulated 
with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 24, 48, 
and 72 hrs for LT-α mRNA quantification by real-time RT-PCR.  Results are expressed as fold change 
relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
     
 
3.3.2.11    Temporal effect of β-hematin on NOS-2A transcripts: 
   Patterns of NOS-2A transcript production varied temporally and in magnitude 
among donors (Figure 14).  In response to β-hematin, NOS-2A mRNA fluctuated 
throughout the time course, peaking at levels > 3- to 17-fold over baseline.  Peak 
transcript production was divided among the majority of subjects between 24 and 48 hrs.  
The difference in means between transcript production under stimulated versus control 
conditions was statistically significant at 24, 48, and 72 hrs post-stimulation.  Fold 
change in NOS-2A mRNA expression increased significantly between 4 and 72 hrs (P = 
0.006). 
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Figure 14.  Temporal effect of β-hematin on NOS-2A transcripts.  PBMC were isolated from venous 
blood (70 mL) obtained from nine healthy, malaria-nave donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for NOS-2A mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.2.12    Temporal effect of β-hematin on COX-1 transcripts: 
In the presence of β-hematin, COX-1 transcripts were produced slightly above or 
below baseline levels throughout the 72 hr-time course (Figure 15).  Peak transcript 
production was detected in 6 of 9 subjects at 4 hrs post-stimulation, at which time fold 
change over control conditions was statistically significant (P < 0.01).  With the 
exception of one donor, fold change in COX-1 mRNA did not exceed 2 times that 
observed in unstimulated cells.   
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Figure 15.  Temporal effect of β-hematin on COX-1 transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from three healthy, malaria-naïve donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for COX-1 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
-1
0
1
2
3
4
5
4hrs 8hrs 24hrs 48hrs 72hrs
Time (hrs)
C
O
X-
1 
m
R
N
A
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
1
2
3
4
5
6
7
8
9**
**P < 0.01
C
O
X-
1 
m
R
N
A
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
C
O
X-
1 
m
R
N
A
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
C
O
X-
1 
m
R
N
A
(F
ol
d 
C
ha
ng
e 
ov
er
 C
on
tr
ol
)
 
 
3.3.2.13    Temporal effect of β-hematin on COX-2 transcripts: 
  COX-2 mRNA expression was detectable at 4 hrs post-stimulation, 
progressively increasing at 8 and 24 hrs (Figure 16).  Transcript production peaked in the 
majority of subjects at 24 hrs, reaching levels from > 17- to 180-fold over those observed 
under unstimulated conditions.  β-hematin induced a progressive decrease in COX-2 
transcripts at 48 and 72 hrs in these individuals.  The difference in means between COX-
2 mRNA expression under stimulated versus baseline conditions was statistically 
significant at all time points.  Relative to the 4-hr time point, fold change in COX-2 
transcript production was significantly elevated at 8 (P < 0.0001) and 48 hrs (P = 0.003). 
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Figure 16.  Temporal effect of β-hematin on COX-2 transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from three healthy, malaria-naïve donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for COX-2 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.3    Anti-inflammatory mediator production 
 
3.3.3.1    Temporal effect of β-hematin on IL-4 transcripts: 
 β-hematin induced patterns of IL-4 mRNA expression that varied markedly 
among donors (Figure 17).  At 4 hrs, IL-4 transcripts were detectable at levels near 
baseline.  IL-4 mRNA levels began to peak at 8 hrs post-stimulation and fluctuated over 
time.  β-hematin produced a 3- to 26-fold increase in IL-4 mRNA at 72 hrs, at which time 
the majority of donors exhibited peak transcript production.  IL-4 fold change over 
control was statistically significant at 4, 48, and 72 hrs post-stimulation. 
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Figure 17.  Temporal effect of β-hematin on IL-4 transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from three healthy, malaria-naïve donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for IL-4 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.3.2    Temporal effect of β-hematin on IL-10 transcripts: 
  β-hematin-induced IL-10 mRNA was detectable at 4 hrs post-stimulation in most 
subjects (Figure 18).  5 of 9 donors exhibited a decrease in IL-10 mRNA expression at 
8hrs, while the remainder showed an increase in transcript production. Peak IL-10 
transcript production occurred at 24 hrs, at levels ranging from near baseline to > 13-fold 
over unstimulated cells.  IL-10 mRNA synthesis decreased at 48 hrs in the majority of 
donors, becoming suppressed by 72 hrs.  Fold change in IL-10 mRNA expression was 
statistically significant at 4, 24, and 48  hrs (P < 0.05). 
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Figure 18.  Temporal effect of β-hematin on IL-10 transcripts.  PBMC were isolated from venous blood 
(70 mL) obtained from three healthy, malaria-naïve donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for IL-10 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
3.3.3.3    Temporal effect of β-hematin on TGF-β1 transcripts: 
 In the presence of β-hematin, TGF-β1 transcript production fluctuated near 
baseline levels at 4, 8, and 24 hrs in the majority of malaria-naïve donors (Figure 19).  
Peak TGF-β1 transcript production occurred at 72 hrs in most subjects (3), but was 
equally distributed between the 8-, 24-, and 48-hr time points among the remaining 6 
donors.  TGF-β1 mRNA expression peaked at levels approximately 2 to 4 times greater 
than those detected in unstimulated cells.  The difference in means between TGF-β1 
transcript production under stimulated versus baseline conditions was statistically 
significant at all time points.  Overall, fold change in TGF-β1 mRNA  increased 
significantly between 4 and 72 hrs (P = 0.004). 
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Figure 19.  Temporal effect of β-hematin on TGF-β1 transcripts.  PBMC were isolated from venous 
blood (70 mL) obtained from three healthy, malaria-naïve donors.  Cultured PBMC (106 cells/mL) were 
stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells at 4, 8, 
24, 48, and 72 hrs for TGF-β1 mRNA quantification by real-time RT-PCR.  Results are expressed as fold 
change relative to unstimulated (baseline) conditions.  Values shown are the means ± SEM of results from 
duplicate samples at each time point.  Statistical significance was determined by paired t-tests.  * denotes 
statistical significance of stimulated versus baseline conditions at P < 0.05.  ** denotes statistical 
significance of stimulated versus baseline conditions at P < 0.01. 
 
 
Overall, real time RT-PCR analyses revealed an early and predominantly pro-
inflammatory response to β-hematin that varied in magnitude among malaria-naïve 
individuals.  Temporal patterns of β-hematin-induced transcript production were similar 
among individuals for IL-1β, IL-6, IL-12p40, IL-18, TNF-α, LT-α, COX-1, COX-2, IL-
4, and IL-10.  IL-2, IL-12p35, IFN-α, IFN-γ, NOS-2A, and TGF-β1 mRNA expression 
were more variable among donors.  Although IL-10 was also induced, it did not suppress 
pro-inflammatory mediator production within 72 hrs of β-hematin stimulation.  TGF-β1 
was expressed at near baseline levels in the majority of individuals and did not appear to 
serve an immunoregulatory role.  In addition, increases in IL-4 mRNA expression at 72 
hrs post-stimulation may indicate a switch from a pro-inflammatory (Th1) to an anti-
inflammatory (Th2) immune response. 
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4.0 DISCUSSION 
 
4.1 Effect of hemozoin on hematological outcomes in infants and children with 
malarial anemia 
One aim of this study was to examine the in vivo effects of hemozoin on 
hematological indices, as a measure of the physiological dysregulatory processes that 
lead to malarial anemia.  Analyses of complete blood counts obtained from healthy 
children, children with uncomplicated malaria, and children with mild, moderate, or 
severe malarial anemia, revealed that several factors were significantly associated with 
disease status (Table 1).  Age was determined to be significantly different among clinical 
groups, and those subjects in the SMA group were the youngest at enrollment.  Mean 
axillary temperature was significantly associated with clinical category, although further 
analyses must be performed to determine whether temperature is predictive of disease 
severity.  However, previous studies in African children residing in areas of holoendemic 
malaria transmission have demonstrated that while fever is associated with parasitemia, it 
is not correlated with MA (Ong’echa et al., 2006; Smith et al., 1995). 
Results of these analyses indicated that neither parasitemia nor the prevalence of 
high-density parasitemia (HDP) were significantly different among clinical groups.  This 
finding is in agreement with previous studies showing that concurrent parasitemia levels 
are not predictive of malaria disease severity in this region (McElroy et al., 2000; 
Ong’echa et al., 2006).  Multiple group comparisons of leukocyte, erythrocyte, and 
platelet indices revealed that all of these factors differed significantly between HC, UM, 
MlMA, MdMA, and SMA groups.  Taken together, these findings are in support of the 
hypothesis that ingestion of malarial pigment by mononuclear phagocytes creates 
pathological changes in hematological parameters that contribute to malaria disease 
severity. 
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Since MA is the most common clinical manifestation of hemozoin-induced 
immune dysregulation among infants and young children in areas of holoendemic malaria 
transmission (such as western Kenya), we sought to determine the relationship between 
prevalence of pigment-containing monocytes in the blood of parasitemic children and 
severity of anemia.  Following stratification of study participants according to percent of 
pigment-containing monocytes (0% PCM, ≤ 10% PCM, and > 10% PCM), hematological 
parameters analyzed in Table 1 were compared across pigment categories.  Age was not 
significantly different between pigment categories, but mean axillary temperature was 
still significantly different between groups.  Although an association between parasitemia 
and clinical category or between HDP and clinical category could not be found in 
previous analyses (Table 1), both mean parasitemia and prevalence of HDP were 
significantly associated with % PCM categories (Table 2).  Interestingly, children in the > 
10% PCM group had the highest mean parasitemia, whereas HDP was most prevalent in 
the ≤ 10% PCM group.  In addition to platelet indices, all leukocyte indices except 
granulocyte count were significantly different between pigment categories.  As when 
compared across clinical categories, most erythrocytic factors differed significantly 
between monocyte pigment categories.  Mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration 
(MCHC) were not, however, significantly different between pigment groups.  Consistent 
with the hypothesis that pigment-induced phagocyte incapacitation leads to MA, mean 
RBC counts, hematocrit, and Hb levels were lowest in the > 10% PCM category, and 
proportion of subjects with SMA were highest.  Taken together, these results suggest that 
the dysregulatory processes involved in the development of MA are mediated, at least in 
part, by the ingestion of hemozoin by peripheral blood monocytes. 
 
4.2 Effect of hemozoin on inflammatory mediator production in infants and  
children with malarial anemia 
The second aim of this study was to determine whether innate inflammatory 
mediator production in infants and children with varying degrees of malarial anemia is 
related to disease severity and/or to percent of pigment-containing monocytes.  
Specifically, differences between the plasma cytokine levels of children with 
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uncomplicated malaria (UM) and children with severe malarial anemia (SMA) were 
examined to elucidate the potential involvement of these cytokines in the development of 
uncomplicated versus severe disease. 
Results detailed in Table 3 revealed that plasma levels of IFN-α, IL-4, IL-6, IL-
10, and IL-12p40/p70 were significantly different among HC, UM, MlMA, MdMA, and 
SMA clinical categories.  IFN-α has been shown to induce NOS-2 and NO production, 
which are essential for an effective pro-inflammatory response to malaria parasites 
(Sharara et al., 1997).  Likewise, IL-12 production is inversely associated with risk of 
severe malaria and positively associated with hemoglobin levels (implying protection 
from MA) (Dodoo et al., 2002; Luty et al., 2000; Perkins et al., 2000).  Equally important 
is the role of IL-10 in regulating the production of pro-inflammatory cytokines that 
contribute to malarial pathogenesis.   Therefore, it is not surprising that plasma IFN-α, 
IL-10, and IL-12p40/p70 levels would differ among individuals with varying degrees of 
disease severity.  Due to its function in fever induction and acute phase protein secretion, 
IL-6 might also be expected to play a central role in the early pro-inflammatory response 
that determines protection against malaria, and therefore, to differ among disease 
categories.  Furthermore, since IL-4 enhances IL-12 production by amplifying 
transcription of the genes encoding the IL-12p35 and p40 subunits (D’Andrea et al., 
1995; Marshall et al., 1997), it follows that plasma levels of IL-4 may differ between HC, 
UM, MlMA, MdMA, and SMA groups if IL-12 levels were determined to be statistically 
significant between these clinical groups.  Differences in IL-4 levels may also reflect a 
shift in the balance between Th1 and Th2 cells that has been shown to exist among 
malaria-exposed individuals in P. falciparum-endemic areas (Elghazi et al., 1997).  In 
these individuals, increased ratios of IL-4/IFN-γ-producing cells facilitate production of 
elevated plasma IgE, which is thought to be required for complete elimination of 
parasitemia (Elghazi et al., 1997; Stevenson and Riley, 2004).  
However, multiple group comparisons indicated that plasma levels of IFN-γ, 
TNF-α, IL-1β, and IL-2 were not significantly different between clinical categories.  It is 
unexpected that plasma TNF-α, IL-1β and IFN-γ levels did not differ significantly 
between clinical categories, since these cytokines mediate both protective and 
pathological immune responses in malaria.  For example, while TNF-α is required for an 
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effective pro-inflammatory response, high levels of TNF promote development of severe 
pathology and MA (Clark and Chaudri, 1988; Grau et al., 1989; Keller et al., 2006; 
Kwiatkowski et al., 1990).  Overproduction of IL-1β, which produces the same clinical 
symptoms as TNF-α, has also been linked to malaria disease severity (Kwiatkowski et 
al., 1990; Walsh et al., 1992).  Furthermore, due to its ability to activate macrophages 
and increase NO production, IFN-γ plays a central role in the early pro-inflammatory 
response to malaria infection.  As such, the ability to mount a rapid IFN-γ response has 
been linked to a more favorable clinical outcome in most animal models of malaria and in 
humans (Deloron et al., 1991; Dodoo et al., 2002; Jacobs et al., 1996; Luty et al., 1999; 
Sedegah et al., 1994).  IL-2, which is known to induce TNF-α, might also be expected to 
differ between HC, UM, MlMA, MdMA, and SMA clinical categories.  However, data 
presented here suggest that IL-2 may not be as essential in the early pro-inflammatory 
response.  
Pairwise comparisons of plasma IFN-α, IL-4, IL-6, IL-10, and IL-12p40/p70 
levels in the UM and SMA groups were performed, since differences in levels of these 
cytokines were found to be statistically significant between the five clinical groups.  
Statistical analyses demonstrated that levels of none of these inflammatory mediators 
were significantly different between children with uncomplicated malaria and children 
with severe malarial anemia (Table 3).  This finding suggests that although plasma IFN-
α, IL-4, IL-6, IL-10, and IL-12p40/p70 differ significantly between healthy children and 
those with varying degrees of MA, the development of uncomplicated versus severe 
disease is not necessarily mediated by these cytokines.  Further analyses are required to 
clarify the specific involvement of these cytokines in the  progression to MA. 
Stratification of parasitemic study participants (UM, MlMA, MdMA, and SMA 
groups; n = 155) according to percent of pigment-containing monocytes (%PCM) was 
performed to determine whether plasma cytokine levels were altered by increased loading 
of monocytes with hemozoin (Table 4).  The presence of phagocyte pigment has been 
used as a prognostic indicator of severe malaria infection and an alternative for diagnosis 
(Phu et al., 1994).  In a study by Day et al., 88% of patients treated for severe falciparum 
malaria exhibited symptoms of the disease that persisted after parasite clearance but 
before the clearance of intraphagocytic pigment (Day et al., 1996).  Since the immune 
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dysregulation caused by monocytic ingestion of hemozoin is cytokine-mediated, one 
would expect the degree of cytokine imbalance to be positively correlated with the 
number of hemozoin-containing monocytes.  Accordingly, one might expect  that plasma 
cytokine levels, which modulate such clinical symptoms of malaria as fever, rigors, 
nausea, headache, and fatigue, would vary according to monocyte pigment content.   
Multiple group comparisons revealed that statistical differences in plasma TNF-α 
levels between 0% PCM, ≤ 10% PCM, and > 10% PCM categories were borderline 
significant (P = .051), indicating that monocytic acquisition of hemozoin may impact 
production of this inflammatory mediator.  Children in the ≤ 10% PCM category 
exhibited the highest levels (pg/mL) of TNF-α, whereas plasma TNF-α was lowest 
among children in the 0% PCM group.  TNF-α production was suppressed in the > 10% 
PCM group (47.57 ± 5.28) relative to children with ≤ 10% PCM (61.42 ± 13.06), 
although it was elevated relative to the 0% PCM group (39.92 ± 6.21). This trend 
suggests that elevated production of TNF-α is required in early infection to limit 
parasitemia but may become impaired as blood content of pigment-containing monocytes 
surpasses 10%.  As such, TNF-α production may be suppressed by increased loading of 
monocytes with hemozoin.   
Plasma levels of  IFN-α, IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, and IL-12p40/p70 
were not significantly different between 0% PCM, ≤ 10% PCM, and > 10% PCM 
categories.  Results presented here suggest that plasma levels of these cytokines are not a 
function of the blood content of hemozoin-containing monocytes in parasitemic 
individuals.  However, it is important to note that murine and human dendritic cells 
(DCs) can be activated by hemozoin (as well as synthetic hemozoin) through TLR-9 
(toll-like receptor 9) and are capable of producing cytokines that influence both innate 
and adaptive immune responses (Pichyangkul et al., 2004; Janeway, 2005).  DCs produce 
TNF-α, IL-1, IL-12, IL-6, IL-18, IFN-γ, and IFN-α (Janeway, 2005), but IFN-α is the 
principal cytokine produced by plasmacytoid DCs in response to TLR-9 ligand (Hemmi 
et al., 2000).  Furthermore, whereas hemozoin has been shown to enhance human DC 
maturation (Coban et al., 2002), P. falciparum-infected erythrocytes inhibit the 
maturation of DCs (Urban et al., 1999).  As such, the potential contribution of DCs to 
cytokine dysregulation in malaria warrants further investigation.   
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 4.3 Temporal effect of β-hematin on cytokine and effector molecule transcript 
production in cultured human peripheral blood mononuclear cells   
The final part of this study focused on determining the temporal kinetics of in 
vitro cytokine and effector molecule mRNA expression in severe P. falciparum malaria.  
PBMC isolated from healthy, malaria-naïve donors were stimulated with a 
physiologically relevant dose of β-hematin in order to investigate its impact on de novo 
inflammatory mediator production.  Figure 20 depicts the temporal profile of peak 
cytokine mRNA production among nine donors for those transcripts detected by real time 
RT-PCR. 
57 
         0 
 
stimulation of 
PBMC with 10 
μg/mL β-hematin 
 
 
 
Time (hrs) 
4 8 24 48 
  
 
 
TNF-α 
IL-18 
 
IL-12p40 
IFN-γ 
IL-6 
COX-2 
IL-10 
NOS-2A 
 
 
 
IFN-α 
IL-1β 
IL-2 
NOS-
 
 
TGF-β1 
IL-4 
IL-12p35 
LT-α 
 
2A 
 
 
 
IL-18 
COX-1 
72 
 
 
 
Figure 20.  Temporal model of peak β-hematin-induced cytokine and effector molecule transcript production.  PBMC were isolated from nine healthy, 
malaria-naïve donors.  Cultured PBMC (106 cells/mL) were stimulated with media alone or with β-hematin (10 μg/mL).  RNA was isolated from harvested cells 
at 4, 8, 24, 48, and 72 hrs for mRNA quantification by real-time RT-PCR.  Peak mRNA production of cytokines/effector molecules listed occurred at the time 
points indicated.  Peak IL-18 transcript production was divided among donors between 4 and 8 hrs.  Peak NOS-2A mRNA expression was divided between 24 
and 48 hrs.  Pro-inflammatory cytokines are illustrated in red type, and anti-inflammatory cytokines are illustrated in blue type.  
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 4.3.1    Effect of β-hematin on IL-1β transcripts: 
β-hematin induced patterns of IL-1β transcript production that were temporally 
similar but differed markedly in magnitude among donors (Figure 4).  Peak IL-1β mRNA 
expression occurred at 48 hrs in the majority of subjects, reaching levels > 300- to 2400-
fold over those measured under unstimulated conditions.  Like TNF-α, IL-1 (produced in 
α and β forms) is a pro-inflammatory cytokine that is released by murine macrophages 
and by human monocytes, macrophages, and PBMC in response to malaria infection, and 
has been shown to induce NO generation in vivo (Pichyangkul et al., 1994; Rockett et al., 
1992; Schofield et al., 1993; Wahlgren et al., 1995; Wood and Clark, 1984).  Formerly 
known as “endogenous pyrogen,” IL-1 (in its recombinant form) shares with recombinant 
TNF the ability to generate fever, rigors, nausea, headache, and fatigue in human subjects 
(Clark et al., 2004; Walsh et al., 1992).  Furthermore, high serum levels of IL-1β have 
been associated with the severity of P. falciparum malaria in West Africa (Kwiatkowski 
et al., 1990).  As such, results presented here are not surprising, since IL-1β would play 
an equally important role in the early pro-inflammatory immune response to malaria 
infection.  The magnitude of the observed in vitro responses to a high dose of β-hematin 
may mimic the high levels of IL-1β produced in severe falciparum malaria. 
 
4.3.2    Effect of β-hematin on IL-2 transcripts: 
 IL-2 is synthesized by activated T cells and acts in an autocrine fashion to drive 
their proliferation and differentiation into armed effector T cells (Janeway, 2005).  Th1 
cells secrete IL-2 to induce the proliferation of CD8 T cells.  IL-2 also acts synergistically 
with IL-12 to induce the proliferation of lymphokine-activated killer (LAK) cells and the 
production of IFN-γ (Chan et al., 1991, 1992).   However, the IL-2-induced proliferation 
of NK and T cells can also be inhibited by IL-12 (Perussia et al., 1992).  In murine 
malaria, macrophages, B cells, and bone-marrow-derived dendritic cells (DCs) are 
capable of processing and presenting malaria antigens to T cells and of promoting T cell 
IFN-γ production, but these antigen presenting cells (APCs) have been shown to inhibit 
the production of IL-2 by T cells (Luyendyk et al., 2002; Quin et al., 2001).  
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Furthermore, inhibition of IL-2 production may account for the inadequate responses to 
unrelated antigens that have been observed during acute malaria (Greenwood et al., 1972; 
McGregor and Barr, 1962).   
Results presented here indicated a peak in IL-2 mRNA production at 24 to 48 hrs 
post-stimulation with β-hematin (Figure 5).  IL-2 transcripts increased approximately 2- 
to 18-fold over control conditions at these time points.  This pattern may represent the 
induction of T cell proliferation in response to β-hematin, which would be characteristic 
of the early Th1 type, cell-mediated response that is required for protective immunity to 
malaria during natural infection. 
 
4.3.3    Effect of β-hematin on IL-6 transcripts: 
 β-hematin-induced IL-6 mRNA expression patterns were temporally similar 
among donors but differed in magnitude (Figure 6).  IL-6 transcript production peaked at 
24 hrs, showing a 12- to 1300-fold increase over unstimulated conditions.  Levels of IL-6 
mRNA detected were similar to levels of IL-1β induced by β-hematin (although IL-1β 
transcript production peaked at 48 hrs post-stimulation).  As IL-6 is also an endogenous 
pyrogen and can be induced by TNF-α, LT-α, and IL-1β (Clark et al., 1992; Janeway, 
2005) it may be expected that high levels of IL-6 mRNA would be produced during the 
early phase of the immune response to β-hematin.  The increase in TNF-α and IL-1β 
transcript production that occurred in all donors prior to and at 24 hrs could have 
contributed to the up-regulation of IL-6 mRNA expression observed at 24 hrs. 
 
4.3.4    Effect of β-hematin on IL-12p35 and IL-12p40 transcripts: 
 As mentioned previously, protective immunity against malaria requires an early 
Th1-type, pro-inflammatory response characterized by enhanced production of IL-12 
(Crutcher et al., 1995; Mosmann and Coffman, 1989; Trinchieri, 1993), whereas IL-12 
suppression increases susceptibility to severe malaria (Luty et al., 2000; Perkins et al., 
2000).  The protective effects of IL-12 have been supported by data obtained from 
prospective epidemiological studies in an area of holoendemic P. falciparum 
transmission (Dodoo et al., 2002).  These studies demonstrated that IL-12 production is 
inversely associated with risk of clinical infection and positively associated with 
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hemoglobin concentration and TNF-α and IFN-γ production (Dodoo et al., 2002).  This 
positive association between IL-12 production and hemoglobin levels indicates a possible 
role for IL-12 in protection from malarial anemia as well, a finding that has also been 
supported by rodent studies (Dodoo et al., 2002; Mohan and Stevenson, 1998).   
 Biologically active IL-12 (IL-12p70) is a heterodimeric cytokine comprised of IL-
12p35 and IL-12p40 subunits that are encoded by separate genes (Kobayashi et al., 1989; 
Trinchieri, 1998).  IL-12p35 mRNA is present in numerous cell types, whereas IL-12p40 
mRNA is restricted to cells that produce the bioactive heterodimer (D’Andrea et al., 
1992; Trinchieri, 2003).  Transcription of both genes is induced following cell activation 
by inflammatory stimuli, though fewer p35 transcripts are synthesized, even in activated 
inflammatory cells (Ma and Trinchieri, 2001; Snidjers et al., 1996).  Although IL-12p40 
is produced in excess over IL-12p70, IL-12p35 is secreted only in association with the 
p40 subunit (Kobayashi et al., 1989; Stern et al., 1990; Trinchieri, 2003; Wysocka et al., 
1995).  IFN-γ and the anti-inflammatory cytokines IL-4 and IL-13 augment IL-12 
production in various cells through enhancement of IL-12p35 and IL-12p40 gene 
transcription (D’Andrea et al., 1995; Hayes et al., 1998; Ma et al., 1996).  However, 
unlike IFN-γ, IL-4 and IL-13 act by initially inhibiting transcription of the p40 gene in 
activated cells, and later, by strongly enhancing it (D’Andrea et al., 1995).  IL-10 is the 
most effective suppressor of IL-12p40 gene transcription (Aste-Amezaga et al., 1998). 
Results presented here indicate that individual IL-12p35 transcripts fluctuated 
throughout the time course, but overall, showed a gradual increase to levels 2- to 9-fold 
greater than those observed under unstimulated conditions by 72 hrs (Figure 7).  An 
approximate 5- to 850-fold increase in IL-12p40 mRNA expression was detected in the 
majority of malaria-naïve donors at 24 hrs, after which β-hematin-induced IL-12p40 
transcripts dramatically decreased  (Figure 8).  This is consistent with previous findings 
that IL-12p40 mRNA is restricted to cells that produce biologically active, heterodimeric 
IL-12 in response to an inflammatory event and not present in cultured PBMC from 
healthy donors (D’Andrea et al., 1992; Keller et al., 2005; Ma and Trinchieri, 2001; 
Trinchieri, 2003), and that physiological conditions simulating severe malaria (such as 
exposure to a high dose of β-hematin) further down-regulate IL-12 production (Luty et 
al., 2000).  Taken together, these results suggest an early increase in β-hematin-induced 
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IL-12p40 expression that may have been subsequently suppressed/downregulated by IL-
10.   
 
4.3.5    Effect of β-hematin on IL-18 transcripts: 
Structurally related to IL-1β, IL-18 is a pro-inflammatory cytokine that is 
produced by the same cell populations and under the same activation conditions as IL-12 
(Bazan et al., 1996; Dinarello, 1999).  IL-18 acts synergistically with IL-12 to up-
regulate IFN-γ production by macrophages, T cells and NK cells, and to enhance the 
cytotoxic functions of NK and T cells (Hunter et al., 1997; Micallef et al., 1996; 
Robinson et al., 1997).  Alone, IL-18 is ineffective at inducing IFN-γ, does not induce a 
Th1 type immune response, and may promote Th2 responses (Barbulescu et al., 1998; 
Nakanishi et al., 2001; Walker et al., 2001).  As in the case of IL-12, low levels of IL-18 
have been associated with severe malarial pathology and anemia (Chaisavaneeyakorn et 
al., 2003; Malaguarnera et al., 2002a, 2002b). 
Results of this study show a temporal pattern of β-hematin-induced IL-18 
transcript production similar to that observed with TNF-α (Figure 9).  IL-18 mRNA 
peaked at 4 to 8 hrs and became suppressed in most donors by 24 hrs.  This pattern 
suggests that IL-18 transcription may have been up-regulated concomitantly with IL-12 
mRNA expression (which peaked at 8 and 24 hrs) for the induction of IFN-γ.  Consistent 
with this hypothesis, the majority of subjects exhibited a peak in IFN-γ transcript 
production at 24 to 72 hrs post-stimulation. 
 
4.3.6    Effect of β-hematin on IFN-α transcripts: 
 In addition to its anti-viral properties, IFN-α has been shown to induce increased 
expression of human monocyte NOS activity, NOS-2 antigen and mRNA content, and 
NO production, both in vitro and in vivo (Sharara et al., 1997).  These findings have 
important implications in malaria, since NOS activity and NO production serve protective 
roles in infection by facilitating parasite clearance (Gyan et al., 1994; Kremsner et al., 
1992; Mellouk et al., 1994; Nussler et al., 1991; Rockett et al., 1991; Stevenson et al., 
1995).  Furthermore, the ability to produce NO is a key factor in the development of mild 
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versus severe malaria (Anstey et al., 1996; Kremsner et al., 1996; Perkins et al., 1999).  
Much like IL-12, IFN-α induces IFN-γ production and Th1 responses, yet is capable of 
suppressing IL-12 (Cousens et al., 1999).  IFN-α can also activate NK cells, which have 
been shown to interact with parasitized erythrocytes and to play a role in the innate 
immune response to blood-stage parasites (Artavanis-Tsakonas et al., 2002, 2003b). 
  Findings of this study indicate peaks in IFN-α mRNA expression throughout the 
72-hr time course, but occurring at 48 hrs post-stimulation in the majority of donors 
(Figure 10).  β-hematin-induced IFN-α transcripts fluctuated above and below baseline 
levels, peaking at levels 2- to 13-fold greater than those detected under unstimulated 
conditions.  Donor 9 showed a > 120-fold increase in IFN-α mRNA.  Elevated IFN-α 
transcript production (along with that of other pro-inflammatory cytokines) may have 
contributed to corresponding peaks in NOS-2A mRNA exhibited by donors 1, 5, 6, 8, and 
9.  These results suggest that individuals differ in their abilities to produce IFN-α, and 
that perhaps the role of IFN-α in protective immunity against malaria may not be as 
essential as that of other cytokines.  IFN-α is typically induced by viral infection or by 
the recognition of double-stranded RNA (characteristic of many viruses) (Janeway, 
2005), and since the molecular mechanisms that regulate IFN-α production in malaria are 
unknown at present, the current findings warrant further investigation.  
 
4.3.7    Effect of β-hematin on IFN-γ transcripts: 
Production of IFN-γ by innate and adaptive immune cells plays a critical role in 
the early pro-inflammatory response to malaria infection.  IFN-γ synergizes with TNF-α 
to optimize NO production, which facilitates parasite killing in both mice and humans 
(Jacobs et al., 1996; Kremsner et al., 1995, 1996; Rockett et al., 1991).  In humans, IFN-γ 
production is correlated with protection from clinical attacks of malaria and with 
resistance to reinfection with P. falciparum (Deloron et al., 1991; Dodoo et al., 2002; 
Luty et al., 1999).  Recent studies have shown that NK cells are the first producers of 
IFN-γ following in vitro exposure of malaria-naïve PBMC to P. falciparum-infected 
erythrocytes (Artavanis-Tsakonas and Riley, 2002). These NK cell-mediated IFN-γ 
responses are IL-12-dependent, partially IL-18-dependent, and do not occur in all donors 
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(Artavanis-Tsakonas and Riley, 2002).  Despite the use of β-hematin (instead of live 
parasitized RBCs) to stimulate PBMC, results presented here support such heterogeneity 
in the magnitude of IFN-γ responses between donors (Figure 11).  β-hematin-induced 
IFN-γ mRNA expression fluctuated throughout the time course and peaked at levels 
approximately 4- to 21-fold over baseline conditions at 24 to 48 hrs in the majority of 
individuals.  However, peak transcript production was observed at each of the five time 
points.  This variation in timing and magnitude of IFN-γ responses may reflect 
differences in each donor’s ability to mount a prompt pro-inflammatory response to 
simulated infection.  In addition, peak IFN-γ mRNA production corresponded to peak IL-
12p40 expression in 5 of 9 subjects (donors 3, 4, 6, 7, and 9), suggesting that increased 
IL-12p40 production at these time points augmented IFN-γ gene expression. 
 
4.3.8    Effect of β-hematin on TNF-α transcripts: 
Patterns of TNF-α transcript production were consistent among donors, showing a 
peak in TNF-α mRNA at 4 to 8 hrs post-stimulation that diminished by 72 hrs (Figure 
12).  It is possible that peaks in IL-10 transcript production at 24 hrs (Figure 18) may 
have down-regulated TNF-α gene expression between 24 and 72 hrs.  Consistent with 
experiments in cultured monocytes (Pichyangkul et al., 1994; Keller et al., 2006), these 
results demonstrate that malarial pigment augments TNF-α production. This ability to 
mount a rapid pro-inflammatory response is required for protection against malaria in 
both mice and humans, since TNF-α acts synergistically with IFN-γ to promote 
phagocytosis of pRBCs and NO release by macrophages (Doolan and Good, 1999; 
Kremsner et al., 1995, 1996; Dodoo et al., 2002).  Consequently, TNF-α serves a 
protective role by limiting parasitemia, but has the potential to produce severe pathology 
and anemia at high levels that are characteristic of acute P. falciparum malaria (Clark and 
Chaudri, 1988; Grau et al., 1989; Keller et al., 2006; Kwiatkowski et al., 1990). 
 
4.3.9    Effect of β-hematin on LT-α transcripts: 
 Lymphotoxin-α (LT-α) is another pro-inflammatory cytokine that plays an 
important role in both murine and human models of malaria and shares several functions 
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in common with TNF.  Previously labeled TNF-β, LT (which is divided into α and  β 
categories) has the ability to up-regulate TNF expression and shares a receptor with TNF 
(Owen-Schaub et al., 1989; Schoenfeld et al., 1991).  Like TNF, LT increases cellular 
adhesion to the endothelium through up-regulation of ICAM-1 and VCAM-1 
(intercellular adhesion molecule 1 and vascular cell adhesion molecule 1, respectively) 
and in its recombinant form, induces high levels of IL-6 and hypoglycemia in malaria-
primed mice (Clark et al., 1992; Husson et al., 2000).  Similar to TNF and IL-1, LT can 
be induced by the malaria toxin GPI (glycosylphosphatidylinositol) and has the ability to 
induce NO production in vivo (Ferrante et al., 1990; Rockett et al., 1992; Tachado et al., 
1996).  In addition, up-regulated LT has been identified as the primary mediator of 
murine cerebral malaria, and a TNF promoter polymorphism that increases LT 
transcription is associated with increased risk of cerebral malaria in African children 
(Engwerda et al., 2002; Knight et al., 1999, 2003; McGuire et al., 1994).  Results of this 
study showed an overall increase in LT-α mRNA expression throughout the time course 
(Figure 13).  By 72 hrs, β-hematin produced a > 2- to 8-fold increase in LT-α transcripts, 
consistent with an increasing pro-inflammatory response.  Of interest, expression of LT-
α, which is also a product of B lymphocytes, peaked at the same time as expression of 
IL-4, an activator of B cells.  
 
4.3.10    Effect of β-hematin on NOS-2A transcripts: 
 In response to hemozoin, cells of the innate immune system produce pro-
inflammatory cytokines such as IL-12, IFN-γ, and TNF-α, which increase NO 
production, and anti-inflammatory cytokines such as IL-10 and TGF-β, which down-
regulate NO synthesis (Oswald et al., 1994; Vodovotz et al., 1993).  NO is formed from 
arginine via the action of nitric oxide synthase (NOS) (Moncada and Higgs, 1993; Nathan 
and Xie, 1994).  The NOS family of enzymes includes two forms of NOS that are 
constitutively expressed and activated by high levels of local calcium to maintain 
biological homeostasis (Clark et al., 2004).  Inducible nitric oxide synthase type 2 (NOS-
2, or iNOS) is another form of NOS that operates independently of local calcium 
concentration to generate high levels of NO during an inflammatory event (Clark et al., 
2004; Nathan and Xie, 1994). 
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Several studies support the role of NO as molecular determinant that regulates 
disease severity in malaria.  For example, levels of NO metabolites in plasma and urine 
and expression of NOS-2 in PBMC were shown to be inversely related to disease severity 
in P. falciparum-infected Tanzanian children (Anstey et al., 1996).  In a similar study, 
plasma levels of NO metabolites in Gabonese adults and children were shown to increase 
with disease severity and were related to accelerated parasite clearance and clinical cure 
(Kremsner et al., 1996).  Protection against severe malaria in this same population of 
Gabonese children was later determined to be related to a promoter polymorphism in the 
NOS-2 gene, which greatly enhanced NO production in response to inflammatory stimuli 
(Kun et al., 1998, 2001).  More recently, elevated NOS-2 activity and NO production 
have been implicated in the pathogenesis of malarial anemia (Keller et al., 2004b). 
Results of this study illustrate inter-individual variation in the ability to generate 
NO following exposure to β-hematin (Figure 14).  Peaks in NOS-2A transcript 
production were detected at 24 to 48 hours post-stimulation in most donors, at levels 3 to 
17 times those observed under unstimulated conditions.  However, peaks in NOS-2A 
mRNA synthesis also occurred as early as 8 hrs and as late as 72 hrs, which indicates that 
genetic variation among individuals (such as promoter polymorphisms) may account for 
their ability to mount a more rapid inflammatory response.  In addition, timing of NOS-
2A transcript production may have been influenced by levels of both pro- and anti-
inflammatory cytokines being generated in these individuals.  For example, elevated 
levels of IL-12, TNF-α, IFN-α, or IFN-γ mRNA would have augmented NOS-2A 
expression.  Conversely, increased IL-10 transcript production could have down-
regulated NOS-2A gene expression through suppression of IL-12 or TNF-α.  Likewise, 
TGF-β1 may have elicited decreases in NOS-2A transcripts via inhibition of TNF-α or 
IFN-γ mRNA synthesis. 
 
4.3.11    Effect of β-hematin on COX-1 and COX-2 transcripts: 
 Cyclooxygenase-1 (COX-1) and cyclooxegenase-2 (COX-2) are enzymatic 
mediators of prostaglandin synthesis (Appleton et al., 1996; Vane et al., 1998).  
Prostaglandins (such as prostaglandin E2, PGE2) are effector molecules that regulate 
macrophage function, cytokine production, fever, vascular permeability, and adhesion 
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molecule expression (Vane et al., 1998).  COX-1, which is constitutively expressed in 
numerous tissues, is involved in the generation of prostaglandins for homeostatic 
purposes (Seibert and Masferrer, 1994). COX-2 is inducibly expressed for the generation 
of high levels of prostaglandins in response to inflammatory stimuli (Seibert and 
Masferrer, 1994).  Previous studies in our lab have demonstrated that reduced plasma 
levels of PGE2, reduced PBMC COX-2 gene expression, and increased plasma levels of 
IL-10 are associated with enhanced severity of P. falciparum malaria (Perkins et al., 
2001).  Although IL-10 can suppress COX-2 gene expression (Niiro et al., 1995), 
subsequent investigations confirmed that the molecular mechanisms by which hemozoin-
induced suppression of COX-2 transcription and PGE2 production occur are independent 
of increased IL-10 production (Keller et al., 2004a).  Results of the present study indicate 
a pattern of COX-2 mRNA expression that was temporally similar among malaria-naive 
donors but varied in magnitude (Figure 16).  β-hematin produced a peak in COX-2 
transcripts at 24 hrs that ranged in magnitude from > 17- to 180-fold over baseline 
conditions.  Elevated levels of COX-2 transcripts at 24 hrs may have contributed to the 
decrease in TNF-α and IL-12p40mRNA expression observed among donors at 24 and at 
48 to 72 hrs, respectively, through increased PGE2 production.  COX-2 mRNA 
expression was subsequently downregulated  at 48 to 72 hrs post-stimulation.  The 
temporal pattern of this pro-inflammatory response is similar to that observed in previous 
studies in our lab, in which cultured PBMC were stimulated with hemozoin (Keller et al., 
2004a). COX-1 transcripts fluctuated slightly above or below baseline conditions 
throughout the time course (Figure 15).  This pattern is consistent with the homeostatic 
role of COX-1 in prostaglandin synthesis, since COX-1 transcripts would not be expected 
to increase in response to β-hematin. 
 
4.3.12    Effect of β-hematin on IL-4 transcripts: 
Similar to IL-10, IL-4 is an anti-inflammatory cytokine that polarizes the immune 
response toward a Th2-type response by activating B lymphocytes to up-regulate the 
production of malaria-specific antibodies (Luoni et al., 2001).  Anti-malaria antibodies 
function to block invasion of sporozoites into hepatocytes and invasion of merozoites into 
erythrocytes, prevent binding of infected erythrocytes to the vascular endothelium and 
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subsequent sequestration, inhibit induction of the inflammatory cytokine cascade by 
neutralizing parasite GPI, and prevent zygote development by mediating complement-
dependent lysis of gametes (Good, 2001; Good and Doolan, 1999; Schofield et al., 2002; 
Sherman, 1998).  During liver-stage and blood-stage malaria, activated NKT cells 
respond rapidly to antigen-specific or polyclonal stimulation by producing high levels of 
both IL-4 and IFN-γ, which modulate adaptive immunity and the polarization of Th cells 
(Hansen et al., 2003; Roura-Mir and Moody, 2003; Schmieg et al., 2003; Sköld and 
Behar, 2003).  Winkler et al. have shown that IFN-γ, rather than IL-4, plays a 
predominant role in parasite clearance during uncomplicated P. falciparium malaria 
(Winkler et al., 1998).  However, others believe that while innate immune mechanisms 
may limit parasite density, adaptive immune mechanisms ultimately are required for 
complete parasite elimination (Stevenson and Riley, 2004).  In support of this notion, 
other studies have demonstrated a shift in the balance between Th1 and Th2 cells in 
malaria-primed individuals residing in P. falciparum-endemic areas (Elghazi et al., 
1997).  Compared to malaria-naïve persons, these individuals have elevated anti-P. 
falciparum plasma IgE levels, which correlate with an increased ratio of IL-4/IFN-γ-
producing cells (Elghazi et al., 1997).  In another study, iron deficiency and high IL-4 
mRNA expression levels in Kenyan children were associated with protection from 
clinical malaria (Nyakeriga et al., 2005).   
Results presented here show that patterns of IL-4 gene expression varied greatly 
among malaria-naïve individuals (Figure 17).  Detectable at near baseline levels at 4 hrs 
post-stimulation, β-hematin-induced IL-4 transcripts fluctuated throughout the time 
course, peaking at 72 hrs in the majority of donors.  Overall, these findings suggest a 
predominantly pro-inflammatory early immune response to β-hematin, and the absence 
of an IL-4-induced anti-inflammatory (Th2) response within 3 days of stimulation.  This 
pattern might be expected in malaria-naïve donors lacking the high number of IL-4-
producing cells present in malaria-exposed individuals.  Furthermore, β-hematin lacks the 
parasite antigens present in live parasites and probably would not elicit an antibody-
mediated immune response.  However, the 3- to 26-fold increase in IL-4 mRNA observed 
at 72 hrs may be indicative of the switch to a Th2 immune response. 
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4.3.13    Effect of β-hematin on IL-10 transcripts: 
Due to its anti-inflammatory properties, IL-10 serves an immunomodulatory role 
in malaria infection by inhibiting the production of pro-inflammatory cytokines that may 
cause pathology in the host.  IL-10 limits TNF-α production, which can promote anemia 
at high levels (Ho et al., 1995, 1998).  Murine models of malaria and experiments in 
cultured monocyte-derived macrophages have demonstrated that IL-10 negatively 
regulates IL-12 production (Aste-Amezaga et al., 1998; Xu et al., 2001).  Studies in our 
lab have shown that children with malarial anemia and hyperparasitemia residing in an 
area of hyperendemic P. falciparum transmission (Gabon) have decreased plasma levels 
of IL-12 and increased  levels of both TNF-α and IL-10 (Luty et al., 2000; Perkins et al., 
2000).  More recent investigations in an area of holoendemic malaria transmission 
(western Kenya) have confirmed that hemozoin-induced over-production of IL-10 is 
responsible for suppression of IL-12 (Keller et al., manuscript submitted).  
Results of this study indicate a peak in β-hematin-induced IL-10 transcript 
production among malaria-naïve individuals at 24 hrs post-stimulation (Figure 18).  
Though individual responses differed in magnitude, this increase in IL-10 mRNA 
suggests an attempt at immunoregulation through down-regulation of pro-inflammatory 
cytokine production (TNF-α, IL-12) and a switch to a Th2 type immune response.  This 
hypothesis is supported by the fact that a peak in IL-10 transcript production followed 
surges in TNF-α mRNA at 4 to 8 hrs and in IL-12 mRNA from 4 to 24 hrs.  
 
4.3.14    Effect of β-hematin on TGF-β1 transcripts: 
Known for its immunoregulatory properties, TGF-β maintains the balance 
between protection from and progression toward severe malaria by negatively regulating 
both innate and adaptive immune responses (Perkins et al., 2000; Stevenson and Riley, 
2004).  Produced by macrophages, NK cells, T cells, and B cells, TGF-β possesses 
concentration-dependent pro- and anti-inflammatory properties (Wahl, 1994).  At low 
concentrations, TGF-β has pro-inflammatory properties, whereas high levels of TGF-β 
produce anti-inflammatory effects (Omer et al., 2000). Among its pro-inflammatory 
properties is the ability to increase the expression of adhesion molecules that attract 
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immune cells to sites of inflammation (Omer et al., 2000).  Anti-inflammatory functions 
of TGF-β include the suppression of TNF and NO production from macrophages, 
suppression of TNF and IFN-γ production from NK cells, and up-regulation of IL-10 
(Omer et al., 2000).  In addition, IL-10 may synergize with TGF-β to suppress IL-2, IL-4, 
and IL-12 production, facilitating the shift from a Th1-type immune response to a Th2-
type response (Omer et al., 2000).  However, unlike IL-10, TGF-β is also capable of 
inhibiting IL-12 through destabilization of IL-12p40 mRNA (Du and Sriram, 1998).  
Whereas TGF-β initially up-regulates cell-mediated Th1-type responses that control 
parasitemia, it later suppresses these responses to reduce the pathological effects of 
inflammation.   
Of interest, one murine model of malaria infection has demonstrated that a surge 
of TGF-β within the first two days of P. yoelii blood-stage infection inhibits early pro-
inflammatory cytokine responses to infection, thus leading to uncontrolled parasite 
growth and death (Omer et al., 2003a).  A more recent study illustrated the ability of 
malaria parasites to activate latent, endogenous TGF-β to its bioactive form, thereby 
modulating the host immune response (Omer et al., 2003b).  In support of results 
obtained from mouse models, human studies have shown an inverse relationship between 
plasma levels of TGF-β and malaria disease severity (Chaiyaroj et al., 2004; 
Malaguarnera et al., 2002a; Musumeci et al., 2003).  Thus, favorable clinical outcomes to 
infection depend not only on an appropriate balance between TGF-β and pro-
inflammatory cytokines such as IL-12 and IL-18, but also on the timing of TGF-β 
induction in the host (Ndungu et al., 2005; Omer et al., 2003a). 
Results presented here demonstrate that in the presence of β-hematin, TGF-β1 
mRNA fluctuated at levels near and slightly above baseline conditions, increasing to 
approximately 2- to 4-fold over control between 8 and 72 hrs (Figure 19).  This pattern of 
low-level TGF-β1 expression in the first 1 to 3 days post-stimulation would be consistent 
with the desired pattern of TGF-β production during natural infection.  At low 
concentrations, TGF-β would have a protective pro-inflammatory effect (needed to 
control parasitemia) and would not inhibit synthesis of other pro-inflammatory cytokines.  
Variation in the timing of increased TGF-β1 transcript production among individuals 
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may represent each donor’s unique response to the β-hematin-induced increase in 
synthesis of pro-inflammatory cytokines. 
Taken together, results presented here illustrate that the temporal kinetics of β-
hematin-induced cytokine transcript production appear to be similar among individuals 
for IL-1β, IL-6, IL-12p40, IL-18, TNF-α, LT-α, COX-1, COX-2, IL-4, and IL-10.  IL-2, 
IL-12p35, IFN-α, IFN-γ, NOS-2A, and TGF-β1 mRNA expression were more variable 
among donors.  In summary, these findings support well-established patterns of cytokine 
production during malaria infection. Although the complex interplay between pro-
inflammatory and anti-inflammatory cytokines cannot be determined from the current 
data, it appears that in malaria-naive donors, a physiologically relevant dose of malarial 
pigment induces an early and robust pro-inflammatory immune response.  As expected, 
IL-10 was also induced, but seemed not to suppress pro-inflammatory cytokine transcript 
production within 72 hrs of β-hematin stimulation.  TGF-β1 mRNA was produced near 
baseline levels throughout the time course, which suggests that it did not serve an 
immunoregulatory role within the first 72 hrs of simulated infection.  IL-4 transcripts 
fluctuated at low levels but increased at 72 hrs post-stimulation, possibly indicating the 
switch to a Th2 immune response.  Importantly, the temporal sequence of cytokine 
induction observed differs from the predicted model of innate immune responsiveness to 
malaria (Figure 3), in which TNF-α is induced by IL-12 and IFN-γ.  Results of the 
present in vitro study indicate that peak β-hematin-induced TNF-α transcript production 
precedes IL-12 and IFN-γ expression (Figure 20).  In addition, data presented here reflect 
heterogeneity in the magnitude of cytokine responses between individuals, perhaps due to 
genetic polymorphisms.  
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5.0    CONCLUSIONS 
 
In conclusion, results of this study confirm that malarial pigment modifies 
hematological parameters, thereby promoting pathological changes that result in malarial 
anemia and severe disease.  The development of MA is mediated, at least in part, by the 
phagocytosis of hemozoin by peripheral blood monocytes.  Plasma levels of IFN-α, IL-4, 
IL-6, IL-10, and IL-12p40/p70 were found to differ significantly between healthy 
children, children with uncomplicated malaria, and children with mild, moderate or 
severe MA, but not specifically between UM and SMA clinical groups. Such findings 
imply that these cytokines do not necessarily mediate the development of uncomplicated 
versus severe disease.  Although they have been shown to play prominent protective and 
pathogenic roles in malaria infection, plasma IFN-γ, TNF-α, IL-1β, and IL-2 were not 
significantly different between clinical categories. Among parasitemic children, plasma 
levels of neither IFN-α, IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, nor IL-12p40/p70  were 
significantly associated with percent of pigment-containing monocytes.  Differences in 
plasma TNF-α between 0%, ≤ 10%, and > 10% PCM categories approached statistical 
significance at P = .051.  Ongoing studies in our laboratory are aimed at investigating the 
relationship between monocytic acquisition of hemozoin and inflammatory mediator 
production in the development of MA.  
Based on further results of this study, temporal profiles of β-hematin-induced IL-
1β, IL-2, IL-6, IL-12p35, IL-12p40, IL-18, IFN-α, IFN-γ, TNF-α, LT-α, NOS-2A, COX-
1, COX-2, IL-4, IL-10, and TGF-β1 mRNA expression were established.  Overall, 
patterns of cytokine transcript production revealed an early pro-inflammatory response to 
malarial pigment that varied in magnitude among malaria-naïve individuals.  Additional 
studies are required to address the role of genetic variation in shaping individual cytokine 
responses to P. falciparum.  Findings presented here are significant, in that inflammatory 
mediators produced by innate immune cells shape the adaptive immune response to 
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Plasmodium parasites.  A better understanding of the molecular mechanisms governing 
these responses will facilitate the development of more effective vaccines and therapeutic 
strategies. 
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